UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from           to          

 

Commission File No. 001-40921

 

ATHENA CONSUMER ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   87-1178222
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

442 5th Avenue

New York, NY

(Address of Principal Executive Offices, including zip code)

 

(970) 925-1572

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and one-half of one redeemable warrant   ACAQ.U   NYSE American LLC
Shares of Class A common stock, par value $0.0001 per share, included as part of the units   ACAQ   NYSE American LLC
Redeemable warrants included as part of the units   ACAQ WS   NYSE American LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  ☐ Large accelerated filer ☐ Accelerated filer
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes  No ☐

 

As of November 14, 2023, there were no shares of Class A common stock, par value $0.0001 per share, issued and outstanding, and no shares of Class B common stock, $0.0001 par value, issued and outstanding.

 

 

 

 

 

  

ATHENA CONSUMER ACQUISITION CORP.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

    Page
PART I – FINANCIAL INFORMATION 1
     
Item 1. Interim Financial Statements (Unaudited) 1
     
  Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 1
     
  Condensed Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (Unaudited) 2
     
  Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2023 and 2022 (Unaudited) 3
     
  Condensed Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (Unaudited) 4
     
  Notes to Condensed Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 27
     
Item 4. Control and Procedures 27
     
PART II – OTHER INFORMATION 28
     
Item 1. Legal Proceedings 28
     
Item 1A. Risk Factors 28
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosures 29
     
Item 5. Other Information 29
     
Item 6. Exhibits 30
     
SIGNATURE 31

  

i

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 

ATHENA CONSUMER ACQUISITION CORP.

CONDENSED BALANCE SHEETS

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS        
CURRENT ASSETS        
Cash  $8,536   $13,612 
Cash – restricted   17,864    
 
Prepaid expenses and other assets   40,501    261,230 
Cash held in Trust Account for redeemed shares   8,668,990    
 
Prepaid income taxes   59,926    
 
Total current assets   8,795,817    274,842 
Cash and Investments held in Trust Account   2,004,215    21,752,492 
TOTAL ASSETS  $10,800,032   $22,027,334 
           
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Accounts payable and accrued expenses  $6,240,443   $3,304,154 
Income tax payable   
    674,933 
Franchise tax payable   17,864    58,857 
Excise tax payable   203,048    
 
Due to related parties   82,605     
Promissory note - related party, net of discount   1,414,717    
 
Due to redeeming Stockholders   8,668,990    
 
Total current liabilities   16,627,667    4,037,944 
           
Derivative liability – Forward Purchase Agreement   
    1,730,000 
Deferred underwriting fee payable   8,650,000    8,650,000 
TOTAL LIABILITIES   25,277,667    14,417,944 
           
COMMITMENTS AND CONTINGENCIES   
 
    
 
 
           
COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION          
Class A common stock subject to possible redemption, $0.0001 par value, 181,460 and 2,048,936 shares at redemption value of $11.02 and $10.28 per share at September 30, 2023 and December 31, 2022, respectively   1,999,598    21,061,039 
           
STOCKHOLDERS’ DEFICIT          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at September 30, 2023 and December 31, 2022   
    
 
Class A common stock; $0.0001 par value; 100,000,000 shares authorized; 1,060,000 shares issued and outstanding (excluding 181,460 and 2,048,936 shares subject to possible redemption) at September 30, 2023 and December 31, 2022   106    106 
Class B common stock; $0.0001 par value; 10,000,000 shares authorized; 8,050,000 shares issued and outstanding at September 30, 2023 and December 31, 2022   805    805 
Additional paid-in capital   359,268    
 
Accumulated deficit   (16,837,412)   (13,452,560)
TOTAL STOCKHOLDERS’ DEFICIT   (16,477,233)   (13,451,649)
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT  $10,800,032   $22,027,334 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

ATHENA CONSUMER ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) 

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
OPERATING EXPENSES                
General and administrative  $2,041,634   $1,271,266   $3,852,870   $2,626,069 
Total operating expenses   (2,041,634)   (1,271,266)   (3,852,870)   (2,626,069)
                     
OTHER INCOME (EXPENSES)                    
Income on investments held in Trust Account   171,680    1,058,835    673,805    1,399,254 
Finance costs – discount on debt issuance   (379,608)   
    (562,316)   
 
Gain on termination of derivative liability – Forward Purchase Agreement   
    (130,000)   1,730,000    (130,000)
Total other income (expense), net   (207,928)   928,835    1,841,489    1,269,254 
                     
LOSS BEFORE PROVISION FOR INCOME TAXES   (2,249,562)   (342,431)   (2,011,381)   (1,356,815)
Provision for income taxes   (34,017)   (196,768)   (130,141)   (256,026)
Net loss  $(2,283,579)  $(539,199)  $(2,141,522)  $(1,612,841)
                     
Weighted average shares outstanding of Class A common stock   2,241,388    24,060,000    2,816,576    24,060,000 
Basic and diluted net loss per share, Class A
  $(0.22)  $(0.02)  $(0.20)  $(0.05)
                     
Weighted average shares outstanding of Class B common stock   8,050,000    8,050,000    8,050,000    8,050,000 
Basic and diluted net loss per share, Class B
  $(0.22)  $(0.02)  $(0.20)  $(0.05)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

  

2

 

 

ATHENA CONSUMER ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023  

  

   Common stock   Additional       Total 
   Class A   Class B   Paid-in   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2022   1,060,000   $106    8,050,000   $805   $   $(13,452,560)  $(13,451,649)
Remeasurement of Class A common stock subject to possible redemption                       (470,123)   (470,123)
Class B common stock to be transferred to fund promissory note                   79,805        79,805 
Net income                       838,087    838,087 
Balance, March 31, 2023 (unaudited)   1,060,000    106    8,050,000    805    79,805    (13,084,596)   (13,003,880)
Remeasurement of Class A common stock subject to possible redemption                       (431,247)   (431,247)
Class B common stock to be transferred to fund promissory note                   79,805        79,805 
Class A common stock to be transferred to fund promissory note                   247,836        247,836 
Net loss                       (696,030)   (696,030)
Balance, June 30, 2023 (unaudited)   1,060,000    106    8,050,000    805    407,446    (14,211,873)   (13,803,516)
Remeasurement of Class A common stock subject to possible redemption                       (341,960)   (341,960)
Class A common stock to be transferred to fund promissory note   

    

    

    

    

151,601

    

    151,601

 
Class B common stock to be transferred to fund promissory note                   3,269        3,269 
Excise tax payable attributable to redemption of Class A common stock                   (203,048)       (203,048)
Net loss                       (2,283,579)   (2,283,579)
Balance, September 30, 2023 (unaudited)   1,060,000   $106    8,050,000   $805   $359,268   $(16,837,412)  $(16,477,233)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

 

   Common stock   Additional       Total 
   Class A   Class B   Paid-in   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2021   1,060,000   $106    8,050,000   $805   $   $(7,310,530)  $(7,309,619)
Net loss                       (222,314)   (222,314)
Balance, March 31, 2022 (unaudited)   1,060,000    106    8,050,000    805        (7,532,844)   (7,531,933)
Net loss                       (851,328)   (851,328)
Balance, June 30, 2022 (unaudited)   1,060,000    106    8,050,000    805        (8,384,172)   (8,383,261)
Remeasurement of Class A common stock subject to possible redemption                       (1,001,219)   (1,001,219)
Initial value of derivative liability – Forward Purchase Agreement                       (1,430,000)   (1,430,000)
Net loss                       (539,199)   (539,199)
Balance, September 30, 2022 (unaudited)   1,060,000   $106    8,050,000   $805   $   $(11,354,590)  $(11,353,679)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

ATHENA CONSUMER ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

   For the Nine Months Ended
September 30,
 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss  $(2,141,522)  $(1,612,841)
Adjustments to reconcile net loss to net cash used in operating activities:          
Finance costs – discount on debt issuance   562,316    
 
Income on investments held in Trust Account   (673,805)   (1,399,254)
Deferred tax asset   
    15,299 
Gain on termination of derivative liability – Forward Purchase Agreement   (1,730,000)   130,000 
Changes in operating assets and liabilities:          
Prepaid expenses and other assets   160,803    198,400 
Accounts payable and accrued expenses   2,936,289    1,687,213 
Due to related parties   82,605     
Income tax and Franchise tax payable   (715,926)   291,215 
Net cash used in operating activities   (1,519,240)   (689,968)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Principal deposited in Trust Account   (860,766)   
 
Cash withdrawn from trust in connection with redemption   11,635,781    
 
Withdrawal from Trust Account for payment of income and franchise taxes   978,077    98,622 
Net cash provided by investing activities   11,753,092    98,622 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from Sponsor loans   1,414,717    
 
Payments for redemptions of Class A common stock   (11,635,781)   
 
Net cash used in financing activities   (10,221,064)   
 
           
Net change in cash   12,788    (591,346)
Cash, beginning of period   13,612    850,615 
Cash, end of period  $26,400   $259,269 
           
Cash, end of period-restricted to pay franchise tax payable  $17,864   $
 
Cash, end of period-unrestricted   8,536    259,269 
TOTAL  $26,400   $259,269 
           
Supplemental cash flow information:          
Cash paid for income taxes  $865,000   $ 
           
Supplemental disclosure of noncash activities:          
Class B Common Stock to be transferred to fund promissory note  $162,879   $
 
Class A Common Stock to be transferred to fund promissory note  $399,437   $
 
Initial value of derivative liability – Forward Purchase Agreement  $
   $1,430,000 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

ATHENA CONSUMER ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2023 (UNAUDITED)

 

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Athena Consumer Acquisition Corp. (the “Company”) was incorporated in Delaware on June 4, 2021. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business Combination”).

 

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023, relates to the Company’s formation and Initial Public Offering (“IPO”), which is described below and, since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO.

 

The registration statement for the Company’s IPO was declared effective on October 19, 2021. On October 22, 2021, the Company consummated the IPO and overallotment option of 23,000,000 units (“Units”) with respect to the Class A common stock included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $230,000,000, which is discussed in Note 3.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 1,060,000 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Athena Consumer Acquisition Sponsor LLC (the “Sponsor”) generating gross proceeds of $10,600,000, which is described in Note 4.

 

Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $13,116,818, consisting of $4,000,000 of underwriting fees, $8,650,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $466,818 of other costs. As described in Note 6, the $8,650,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement.

 

Following the closing of the IPO and exercise of the over-allotment, $234,600,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a Trust Account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo.

 

5

 

 

On December 16, 2022, the Company issued a press release announcing that, in connection with a special meeting of stockholders (the “Extension Meeting”) to be held for the purpose of considering and voting on, among other proposals, a proposal to amend the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) to provide the Company with the right to extend the date (the “Deadline Date”) by which it must consummate an initial business combination (the “Extension”) up to six times for an additional one month each time, from January 22, 2023 to up to July 22, 2023, if the Extension Amendment is approved at the Extension Meeting and an Extension is implemented, the Sponsor, or its designees will deposit into the Trust Account as a loan (a “Contribution”, and the Sponsor or its designee making such Contribution, a “Contributor”), the lesser of (x) $121,000 or (y) $0.055 per public share multiplied by the number of public shares outstanding, on each of the following dates: (i) January 23, 2023; and (ii) one business day following the public announcement by the Company disclosing that the Company’s board of directors (the “Board”) has determined to extend the Deadline Date for an additional month in accordance with the Extension (each date on which a Contribution is to be deposited into the Trust Account, a “Contribution Date”).

 

On December 21, 2022, the Company held the Extension Meeting. At the Extension Meeting, the Company’s stockholders approved the Extension Amendment, providing the Company with the right to extend the Deadline Date up to six times for an additional one month each time, from January 22, 2023 (the date which is 15 months from the closing date of the Company’s IPO) to up to July 22, 2023 (the date which is 21 months from the closing date of the IPO).

 

On January 17, 2023, the Board determined to implement a first Extension and to extend the Deadline Date for an additional month to February 22, 2023. On the same date, in connection with the Extension and pursuant to an unsecured promissory note the Company and the Sponsor entered into on January 17, 2023 (the “Extension Note”), the Board delivered to the Sponsor a written request to draw down $112,691 for the first month of the Extension. Upon this written request, the Sponsor deposited the $112,691 to the Company’s Trust Account on January 23, 2023.

 

On January 30, 2023, the Company received notifications via phone calls from the staff of the New York Stock Exchange (the “NYSE”) that it had determined that the Company was not in compliance with the requirements of Section 802.01B of the NYSE Listed Company Manual (the “LCM”), which requires a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly held shares (a “public float”) over a consecutive 30 trading day period of at least $40,000,000.

 

On February 9, 2023, the Company issued a press release announcing that it would transfer its listing to the NYSE American LLC (the “NYSE American”). The Company received written confirmation that it had been cleared to file an initial listing application with the NYSE American on February 6, 2023, and received the final approval for listing from the staff of the NYSE American on February 9, 2023. In connection with listing on the NYSE American, the Company would voluntarily delist from the New York Stock Exchange. Following the transfer of its listing, the Company intends to continue to file the same periodic reports and other information it currently files with the Securities and Exchange Commission. On February 14, 2023, the Company voluntarily delisted its securities from the NYSE and the Company’s securities commenced trading on the NYSE American under the same symbols.

 

On February 17, 2023, the Board determined to implement a second Extension to allow additional time for the Company to complete its initial business combination. In connection with the second Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the second month of the Extension. On the same day, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the second Extension.

 

On March 20, 2023, the Board determined to implement a third Extension to allow additional time for the Company to complete its initial business combination. In connection with the third Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the third month of the Extension. On March 21, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the third Extension.

 

On April 18, 2023, the Board determined to implement a fourth Extension to allow additional time for the Company to complete its initial business combination. In connection with the fourth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the fourth month of the Extension. On April 20, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the fourth Extension.

 

On April 20, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from April 22, 2023 for an additional month to May 22, 2023, the fourth of six potential one-month extensions of the Deadline Date available to the Company.

 

On May 19, 2023, the Board determined to implement a fifth Extension to allow additional time for the Company to complete its initial business combination. In connection with the fifth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the fifth month of the Extension. On May 22, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the fifth Extension.

 

On May 22, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from May 22, 2023 for an additional month to June 22, 2023, the fifth of six potential one-month extensions of the Deadline Date available to the Company then.

 

On June 20, 2023, the Board determined to implement a sixth Extension to allow additional time for the Company to complete its initial business combination. In connection with the sixth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the sixth month of the Extension. On June 21, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the sixth Extension.

 

On June 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from June 22, 2023 for an additional month to July 22, 2023, the last of six potential one-month extensions of the Deadline Date available to the Company then.

 

6

 

 

On July 19, 2023, the Company held a special meeting of its stockholders (the “Second Extension Meeting”). At the Second Extension Meeting, the Company’s stockholders approved (1) a proposal to amend the Company’s amended and restated certificate of incorporation, as amended on December 21, 2022 (the proposed amendment, the “Second Extension Amendment”) to provide the Company with the right to extend the Deadline Date up to three times for an additional one month each time (the “Second Extension”), from July 22, 2023 (the date which is 21 months from the closing date of the IPO) to up to October 22, 2023 (the date which is 24 months from the closing date of the IPO) (the “Second Extension Amendment Proposal”) and (2) a proposal to amend the Company’s amended and restated certificate of incorporation, as amended on December 21, 2022 (the “Redemption Limitation Amendment”, together with the Second Extension Amendment, the “Charter Amendment”) to eliminate (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 (the “Redemption Limitation Amendment Proposal”). The Sponsor, has agreed that if the Second Extension Amendment is implemented, the Sponsor or its designees will deposit into the Trust Account as a loan of $60,000 (the “Second Contribution”) on each of the following dates: (i) July 20, 2023; and (ii) one business day following the public announcement by the Company disclosing that its board of directors has determined to extend the Deadline Date for an additional month in accordance with the Second Extension Amendment.

 

A total of 1,082,596 shares of the Company’s Class A common stock was presented for redemption in connection with the Second Extension Meeting. As a result, there is approximately $10.48 million remaining in the Trust Account as of July 28, 2023 following redemptions.

 

On July 19, 2023, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware.

 

In connection with the Second Contribution, on July 20, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $180,000 (the “Second Extension Note”), and on the same date, the Board delivered to the Sponsor a written request to draw down $60,000 for the first month of the Second Extension. On July 21, 2023, Continental Stock Transfer & Trust Company, the Company’s trustee, confirmed the receipt of the $60,000 Contribution.

 

On August 18, 2023, the Board determined to implement a second of the Second Extension to allow additional time for the Company to complete its initial business combination. In connection with this Extension and pursuant to the Second Extension Note, the Board delivered to the Sponsor a written request to draw down $60,000 for the second month of the Second Extension. On August 21, 2023, the Sponsor deposited $60,000 into the Company’s Trust Account in connection with this Extension.

 

On August 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from August 22, 2023 for an additional month to September 22, 2023, the second of three potential one-month Second Extensions of the Deadline Date available to the Company.

 

On September 15, 2023, the Board determined to implement a third of the Second Extension to allow additional time for the Company to complete its initial business combination. In connection with this Extension and pursuant to the Second Extension Note, the Board delivered to the Sponsor a written request to draw down $60,000 for the third month of the Second Extension. On September 21, 2023, the Sponsor deposited $60,000 into the Company’s Trust Account in connection with this Extension.

 

On September 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from September 22, 2023 for an additional month to October 22, 2023, the last of three potential one-month Second Extensions of the Deadline Date available to the Company.

 

On September 29, 2023, the Company held a special meeting of its stockholders in connection with its proposed business combination. At the special meeting, the Company’s stockholders approved (1) the business combination agreement, dated as of July 28, 2022 (as amended by the amendments to the business combination agreement, dated as of September 29, 2022, June 29, 2023, July 18, 2023, August 25, 2023, September 8, 2023, and September 11, 2023, and as may be further amended or restated from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a European company incorporated in Germany (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”) and the transactions contemplated thereby (the “Business Combination”), pursuant to which, among other things, (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the U.S. Securities and Exchange Commission (“SEC”) guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions. A total of 884,880 shares of the Company’s Class A Common Stock were presented for redemption in connection with the special meeting, 100,000 shares of which subsequently revoked the redemption request, making the actual shares presented for redemption to be 784,880.

 

7

 

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”) (see Note 9).

 

Risks and Uncertainties

 

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) as a pandemic which continues to spread throughout the United States and the world. As of the date the unaudited condensed financial statements were issued, there was considerable uncertainty around the expected duration of this pandemic. Management continues to evaluate the impact of the COVID-19 pandemic, and the Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

 

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the “IR Act”), which, among other things, generally imposes a 1% U.S. federal excise tax (the “Excise Tax”) on certain repurchases of stock by “covered corporations” (which include publicly traded domestic (i.e., U.S.) corporations) occurring on or after January 1, 2023. The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because the Company is a Delaware corporation and its securities are trading on the NYSE American, the Company is a “covered corporation” for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury (the “Treasury”) has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax. On December 27, 2022, the Treasury issued a notice that provides interim operating rules for the Excise Tax, including rules governing the calculation and reporting of the Excise Tax, on which taxpayers may rely until the forthcoming proposed Treasury regulations addressing the Excise Tax are published. Although such notice clarifies certain aspects of the Excise Tax, the interpretation and operation of other aspects of the Excise Tax remain unclear, and such interim operating rules are subject to change.

 

Whether and to what extent the Company would be subject to the Excise Tax on a redemption of shares of Class A common stock or other stock issued by the Company would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the Excise Tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the initial Business Combination, an extension or otherwise, (iii) the structure of the initial Business Combination, (iv) the nature and amount of any “PIPE” or other equity issuances (whether in connection with the initial Business Combination or otherwise) issued within the same taxable year of a redemption treated as a repurchase of stock and (v) the content of forthcoming regulations and other guidance from the Treasury. As noted above, the Excise Tax would be payable by the Company and not by the redeeming holder, and only limited guidance on the mechanics of any required reporting and payment of the Excise Tax on which taxpayers may rely have been issued to date. The imposition of the Excise Tax could cause a reduction in the cash available on hand to complete the initial Business Combination or for effecting redemptions and may affect the Company’s ability to complete the initial Business Combination, fund future operations or make distributions to stockholders. In addition, the Excise Tax could cause a reduction in the per share amount payable to the public stockholders in the event the Company liquidates the Trust Account due to a failure to complete the initial Business Combination within the requisite time frame.

 

On July 19, 2023, the Company’s stockholders elected to redeem 1,082,596 shares for a total payment of $11,635,781. In addition, On September 29, 2023, the Company’s stockholders elected to redeem 784,880 shares for a total payment of $8,668,990. The Company evaluated the classification and accounting of the share/ stock redemption under Accounting Standards Codification (“ASC”) 450, “Contingencies”. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset or the incurrence of a liability can range from probable to remote. A contingent liability must be reviewed at each reporting period to determine appropriate treatment. The Company evaluated the current status and probability of completing a Business Combination as of September 30, 2023 and concluded that it is probable that a contingent liability should be recorded. As of September 30, 2023, the Company recorded $203,048 of excise tax liability calculated as 1% of the shares redeemed.

 

8

 

 

Going Concern and Capital Resources

 

As of September 30, 2023, the Company had $26,400 in its operating bank accounts (inclusive of $17,864 restricted cash to pay for the Company’s franchise taxes), $10,673,205 in securities held in the Trust Account (inclusive of $8,668,990 restricted amount to pay for the redeeming stockholders) to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $7,831,850. As of September 30, 2023, approximately $313,029 of the amount on deposit in the Trust Account represented interest and dividend income, which is available to pay the Company’s redeeming stockholders and tax obligations.

 

On October 19, 2023, as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management believes that the liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern.

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on March 30, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

 

Emerging Growth Company

 

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

9

 

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $8,536 and $13,612 of cash as of September 30, 2023 and December 31, 2022, respectively, and no cash equivalents.

 

Cash - Restricted

 

Cash that is encumbered or otherwise restricted as to its use is included in cash – restricted. As of September 30, 2023 and December 31, 2022, the balance was $17,864 and $0, respectively. Cash – restricted at September 30, 2023 represents cash that was withdrawn from the Trust Account to pay franchise taxes but is yet to be utilized.

 

Cash and Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s cash and investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s cash and investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

As of September 30, 2023 and December 31, 2022, the Company had $10,673,205 and $21,752,492 in cash and investments held in Trust Account, respectively. The balance of $10,673,205 as of September 30, 2023 includes a restricted amount of $8,668,990 which represents the amounts payable to the redeeming stockholders in connection with the special meeting held on September 29, 2023.

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Total offering costs amounted to $13,116,818, out of which $12,245,042 was charged against the carrying value of Class A common stock upon the completion of the IPO.

  

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

 

10

 

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

 

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s effective tax rate was (1.51)% and (57.46)% for the three months ended September 30, 2023 and 2022, respectively, and (6.47)% and (18.87)% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, primarily due to the extinguishment of the derivative liability and valuation allowance on the deferred tax assets.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

Derivative Liabilities

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has determined forward purchase agreements are derivative instruments.

 

Class A Common Stock Subject to Possible Redemption

 

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock sold in the IPO and over-allotment features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 181,460 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

 

Under ASC 480-10-S99, the Company has elected to recognize changes in redemption value immediately as they occur and adjust the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

Immediately upon the closing of the IPO and over-allotment, the Company recognized the accretion from the initial book value to redemption amount value. This method would view the end of the reporting period as if it were also the redemption date of the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

11

 

 

As of September 30, 2023 and December 31, 2022, the shares of Class A common stock subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:

 

Gross proceeds  $230,000,000 
Less:     
Fair value of Public Warrants at issuance   (15,310,355)
Class A shares issuance costs   (12,245,042)
Add:     
Accretion of carrying value to redemption value   32,155,397 
Class A common stock subject to possible redemption at December 31, 2021   234,600,000 
Less: Redemption of common stock subject to possible redemption   (216,004,846)
Plus: Accretion of carrying value to redemption value   2,465,885 
Class A common stock subject to possible redemption, December 31, 2022   21,061,039 
Less: Redemption of common stock subject to possible redemption   (20,304,771)
Add: Accretion of carrying value to redemption value   1,243,330 
Class A common stock subject to possible redemption, September 30, 2023 (unaudited)  $1,999,598 

 

Net Loss per Common Share

 

The Company has two classes of common shares, which are referred to as Class A common stock and Class B common stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares. On September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period presented. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per common share for each class of stock.

 

   For the Three Months Ended September 30, (unaudited) 
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(497,347)  $(1,786,232)  $(404,021)  $(135,178)
                     
Denominator:                    
Weighted average shares outstanding   2,241,388    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.22)  $(0.22)  $(0.02)  $(0.02)

 

   For the Nine Months Ended September 30, (unaudited)  
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(555,074)  $(1,586,448)  $(1,208,501)  $(404,340)
                     
Denominator:                    
Weighted average shares outstanding   2,816,576    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.20)  $(0.20)  $(0.05)  $(0.05)

 

Accounting for Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants (defined below) issued pursuant to the warrant agreements qualify for equity accounting treatment.

 

12

 

 

Recent Accounting Pronouncements

 

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

NOTE 3. INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

 

Pursuant to the IPO, and including the underwriters’ exercise of their over-allotment option, the Company sold 23,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock (such shares of Class A common stock included in the Units being offered, the “Public Shares”), and one-half a redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

 

NOTE 4. PRIVATE PLACEMENT

 

On October 22, 2021, simultaneously with the consummation of the IPO and the underwriters’ exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 1,060,000 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $10,600,000. Each whole Private Placement Unit will consist of one share of Class A common stock and one-half of a redeemable warrant (“Private Placement Warrant”). Each whole Private Placement Warrant will be exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and all underlying securities will be worthless.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On June 4, 2021, the Sponsor was issued 5,900,000 shares of Class B common stock. Subsequently, on June 24, 2021, the Sponsor paid certain costs totaling $25,000 on behalf of the Company as consideration for 5,900,000 issued on June 4, 2021. On September 23, 2021, the Company effected a 1.36440678 for 1 stock split of its common stock so that the Sponsor owns an aggregate of 8,050,000 Founder Shares. The Sponsor paid approximately $0.003 per share for the Founder Shares. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 7. Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment, at any time. The Initial Stockholders had agreed to forfeit up to 1,050,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. Since the underwriters exercised the over-allotment option in full, the Sponsor did not forfeit any Founder Shares.

 

Subject to limited exceptions, each holder of Founder Shares has agreed that, during the period from July 28, 2022 through the earlier to occur of (the “Termination Date”) (a) the closing of the e.GO Transaction (as such term is defined in Note 6) (the “Closing”), (b) such date and time as the Business Combination Agreement (as such term is defined in Note 6) is validly terminated in accordance with its terms and (c) the mutual written agreement of the parties to that certain Sponsor Letter Agreement (as such term is defined in Note 6), except as contemplated by such Sponsor Letter Agreement and the Business Combination Agreement, it shall not, and shall cause its affiliates not to, without the prior written consent of e.GO and the Company (which consent may be given or withheld by e.GO and the Company in their sole discretion), (i) offer for sale, sell (including short sales), transfer, tender, pledge, convert, encumber, assign or otherwise dispose of, directly or indirectly (including by gift, merger, tendering into any tender offer or exchange offer or otherwise) (collectively, a “Transfer”), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer of, any or all of its Founder Shares; (ii) grant any proxies or powers of attorney with respect to any or all of its Founder Shares held by it (except in connection with voting by proxy at a meeting of shareholders of the Company); or (iii) permit to exist any mortgage, pledge, security interest, encumbrance, lien, license or sub-license, charge or other similar encumbrance or interest (including, in the case of any equity securities, any voting, transfer or similar restrictions) (a “Lien”) with respect to any or all of its Founder Shares, other than those created by the Sponsor Letter Agreement; provided that any Lien with respect to the Founder Shares that would not prevent, impair or delay its ability to comply with the terms and conditions of the Sponsor Letter Agreement shall be permitted and will not be deemed to violate the restrictions contained above.

 

Additionally, subject to limited exceptions, each holder of Founder Shares has agreed that for a period from the Closing through the date that is 180 days thereafter, it shall not, and shall cause its affiliates not to, Transfer, or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer of, any or all of its TopCo Covered Shares. “TopCo Covered Shares” means (i) with respect to the Sponsor, 75% of the TopCo Ordinary Shares to be issued to the Sponsor pursuant to the Business Combination Agreement (it being understood that the terms of this paragraph shall not apply to the remaining 25% of such TopCo Ordinary Shares) and (ii) with respect to the Athena Insiders (as such term is defined in Note 6), all of the TopCo Ordinary Shares to be issued pursuant to the Business Combination Agreement.

 

13

 

 

Related Party Loans

 

On June 4, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of December 31, 2021, or the completion of the IPO. An amount of $117,994 was borrowed under the Note and repaid on October 22, 2021. There was no balance outstanding as of September 30, 2023 and December 31, 2022. This facility is no longer available.

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into Units of the post Business Combination entity at a price of $10.00 per Unit. The Units would be identical to the Private Placement Units. As of September 30, 2023, the promissory notes stated below were entered into which fall under the Working Capital Loans structure.

 

On January 17, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $676,149 (the “Extension Note”). On the same date, in connection with advances the Sponsor may make in the future to the Company for working capital expenses in connection with the Company’s initial business combination, the Company issued a separate unsecured promissory note to the Sponsor in the principal amount of up to $400,000 (the “Working Capital Note”, together with the Extension Note, the “Notes”). Both Notes bear no interest and are repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the Company’s liquidation. If the Company does not consummate an initial business combination by the Deadline Date, the Notes will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Notwithstanding the foregoing, under both Notes, following the closing of the Company’s initial business combination, the Sponsor may elect to convert all or any portion of the unpaid principal balance of the Note into units of the post-business combination entity at $10.00 per unit (the “Conversion Units”), with each unit being identical to the private placement units sold to the Sponsor in connection with the Company’s IPO. The Conversion Units and their underlying securities are entitled to the registration rights set forth in the Notes. On May 19, 2023, the Company and Sponsor entered into an amendment and restatement to the Working Capital Note in order to increase the aggregate principal amount of borrowings to an aggregate principal amount of up to $600,000. On July 7, 2023, the Company and Sponsor entered into an amendment and restatement to the Working Capital Note in order to increase the aggregate principal amount of borrowings to an aggregate principal amount of up to $900,000. As of September 30, 2023, the Sponsor funded $738,568, and there is $161,432 available under the Working Capital Note which has not yet funded. The $676,149 Extension Note was fully funded as of September 30, 2023. As of September 30, 2023 and December 31, 2022, the total outstanding balance of the Notes is $1,414,717 and $0, respectively.

 

In connection with the Sponsor’s Contribution for the Second Extension, on July 20, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $180,000 (the “Second Extension Note”). The Second Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the Company’s liquidation. If the Company does not consummate an initial business combination by the Deadline Date, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Notwithstanding the foregoing, under the Second Extension Note, following the closing of the Company’s initial business combination, the Sponsor may elect to convert all or any portion of the unpaid principal balance of the Second Extension Note into Conversion Units at $10.00 per unit, with each unit being identical to the private placement units sold to the Sponsor in connection with the Company’s IPO, provided that the aggregate amount the Sponsor may convert under the Second Extension Note, the Extension Note, and the Working Capital Note, as amended on May 19, 2023 and July 7, 2023, shall not exceed $1,500,000. The Conversion Units and their underlying securities are entitled to the registration rights set forth in the Second Extension Note.

 

In connection with funding the Extension Note, the Sponsor entered into an agreement with a member of the Sponsor. Pursuant to such agreement, the Sponsor agreed to assign and transfer to such member a ratio of 1 Founder Share for every $1.5 amount funded upon the closing of the Business Combination. As of September 30, 2023, such member of the Sponsor loaned $230,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

On May 19, 2023, the Sponsor entered into an agreement with a third party investor. Pursuant to such agreement, the Sponsor will transfer one share of Class A common stock of the Company for each dollar funded upon the closing of a Business Combination. As of September 30, 2023, such third party investor loaned $510,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

Due to Related Parties

 

The balance due to related parties mainly represents the amounts owed by the Company to an entity affiliated with the Sponsor for support services. As of September 30, 2023 and December 31, 2022, the Company has an outstanding due to related parties of $82,605 and $0, respectively.

 

14

 

 

Support Services

 

The Company intends to pay an entity affiliated with the Sponsor a fee of approximately $10,000 per month following the consummation of the IPO until the earlier of the consummation of the Business Combination or liquidation for office space and administrative support services. For the three and nine months ended September 30, 2023, $30,000 and $90,000, respectively, have been incurred and $10,000 has been paid under this agreement. For the three and nine months ended September 30, 2022, $30,000 and $90,000, respectively, have been incurred and paid under this agreement.

 

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of Founder Shares, Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A common stock) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the final prospectus relating to the IPO to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On October 22, 2021, the underwriters elected to fully exercise the over-allotment option purchasing 3,000,000 Units.

 

The underwriters were paid a cash underwriting discount of $0.20 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $4,000,000 in the aggregate at the closing of the IPO. The underwriters have agreed to defer the cash underwriting discount of $0.20 per share related to the over-allotment to be paid upon completion of a Business Combination ($600,000 in the aggregate). In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $8,050,000 from the closing of the IPO. The total deferred fee is $8,650,000, consisting of the $8,050,000 deferred portion and the $600,000 cash discount agreed to be deferred until completion of a Business Combination. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.

 

On December 8, 2022, Citi, as representative of the underwriters, agreed to formally waive the deferred underwriting commissions of $8,650,000 in full, pursuant to a deferred fee waiver letter agreement between Citi and the Company only upon the successful Business Combination under the e.GO transaction as described below.

 

Business Combination Agreement

 

On July 28, 2022, the Company entered into a Business Combination Agreement (as amended by that certain first amendment to the Business Combination Agreement on September 29, 2022, and as it may be further amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a German company (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of TopCo (“Merger Sub”), for the Company’s initial Business Combination (the “e.GO Transaction”). Pursuant to the Business Combination Agreement, among other things, (i) TopCo will issue to the e.GO’s equity securities (the “e.GO Shareholders”) and convertible loan lenders of e.GO (the “Lenders”) an aggregate of up to 79,019,608 TopCo Ordinary Shares, representing aggregate consideration to the e.GO Shareholders of $800,000,000, 30,000,000 of such shares will be unvested and subject to an earn-out (the “Earn-Out Shares”), in exchange for the contribution by the e.GO Shareholders of all of the paid up no-par value shares of e.GO to TopCo and the convertible loans held by the Lenders, assuming that all e.GO Shareholders and Lender participate in the exchange; (ii) each issued and outstanding share of the Company’s Class A common stock will be automatically cancelled and extinguished and converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”), (iii) each issued and outstanding share of the Company’s Class B common stock will be automatically cancelled and extinguished and converted into a number of shares of Surviving Company Common Stock calculated as the sum of (x) one plus (y) the lower of (a) the total amount funded under the credit agreement, dated September 29, 2022, between e.GO, Brucke Funding LLC, Brucke Agent LLC and certain lenders party thereto (the “Bridge Financing”), divided by $15,000,000 and multiplied with one-fifth and (b) one-fifth; (iv) TopCo will change its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (v) Merger Sub will merge with and into the Company, with the Company being the Surviving Company and, after giving effect to the merger, becoming a direct, wholly owned subsidiary of TopCo; (vi) each share of the Company’s common stock will be converted into one share of the Surviving Company Common Stock; (vii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one TopCo Ordinary Share; and (viii) each outstanding warrant to purchase a share of the Company’s Class A common stock will be converted into a warrant to purchase a TopCo Ordinary Share on the same contractual terms and conditions as were in effect with respect to each warrant prior to the e.GO Transaction; and (ix) TopCo, the Company, the Sponsor, certain of the Company’s officers and directors, certain members of the Sponsor and/or their respective affiliates will enter into an amended and restated registration rights agreement pursuant to which TopCo will agree to register for resale, pursuant to Rule 415 of the Securities Act, certain TopCo Ordinary Shares and other equity securities of TopCo that are held by the parties thereto from time to time and the parties thereto will be provided customary demand and piggyback registration rights.

 

15

 

 

On June 29, 2023, the Company entered into a second amendment to the Business Combination Agreement (the “Second Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which, among other things, the following terms of the Business Combination Agreement were amended: (a) Treatment of Athena Class B Common Stock – In connection with the closing of the Business Combination and subject to the approval of the Company’s stockholders, each issued and outstanding share of the Company’s Class B common stock will be converted into 1.05 TopCo ordinary shares, or a conversion of 8,050,000 shares into 8,452,500 shares. The 1:1.05 conversion ratio is a clarification and finalization of the conversion ratio of such shares originally contemplated by the First Amendment to the Business Combination Agreement, which was based on the amount that may have been funded under the Bridge Financing. Final disbursement amounts under the Bridge Financing totaled $3,750,000 out of a maximum of $15,000,000, resulting in a 1:1.05 conversion ratio under the First Amendment to the Business Combination Agreement out of a maximum 1:1.2 conversion ratio; (b) Requisite Lock-up Percentage of e.GO Shareholders and Convertible Note Lenders – The Business Combination Agreement previously required all of e.GO’s shareholders and convertible loan lenders to enter into lock-up agreements pursuant to which they agreed not to effect any sale or distribution of any equity securities of TopCo issued to them at the closing of the Business Combination until the date that is six months after the closing. Pursuant to the Second Amendment to the Business Combination Agreement, such requirement was reduced to restrict the sale or distribution of 75% of the pro forma share capital of e.GO on a fully diluted basis as of the date of the Second Amendment to the Business Combination Agreement; and (c) Outside Date Termination Event – The outside date to terminate the Business Combination Agreement was extended from September 30, 2023 to September 30, 2023.

 

On July 18, 2023, the Company entered into a third amendment to the Business Combination Agreement (the “Third Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which the treatment of the Company’s Class B common stock was amended that, in connection with the closing of the Business Combination, each issued and outstanding share of the Company’s Class B common stock will be converted into TopCo ordinary shares on a one-for-one basis, instead of 1:1.05, as had been the case under the Second Amendment to the Business Combination Agreement. The one-for-one conversion ratio aligns with what is currently in the Company’s Charter.

 

On August 25, 2023, the Company entered into a fourth amendment to the Business Combination Agreement (the “Fourth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which, among other things, certain terms of the Business Combination Agreement (including with respect to the transaction steps, joint covenants of the parties, and the conditions to the obligations of the parties) were amended to reflect:

 

Warrant Exchange. The Business Combination Agreement previously provided that each outstanding warrant to purchase a share of the Company’s Class A common stock, par value $0.0001 per share, of the Company’s (the “Athena Class A Common Stock” and such warrants, the “Athena Warrants”) will be converted into a warrant to purchase a newly issued ordinary share, nominal value €0.12 per share, of TopCo (the “TopCo Share”) on the same contractual terms and conditions as were in effect with respect to each warrant prior to the Business Combination at the closing of the Business Combination (the “Closing”). Pursuant to the Fourth Amendment to the Business Combination Agreement, immediately prior to the Closing, each outstanding Athena Warrant will instead, subject to the approval of warrant holders of the Company, be cancelled and exchanged for 0.175 shares of Class A Common Stock, which will subsequently, in connection with the Closing, be exchanged for newly issued TopCo Shares (the “Warrant Exchange”).

 

Revised Form of Earn-out Agreement. In connection with the proposed Warrant Exchange, the Company and e.GO renegotiated certain terms of the earn-out agreement, which TopCo, the Company and holders of e.GO’s equity securities (the “e.GO Shareholders”) have agreed to enter into prior to the Closing, pursuant to which, among other things, TopCo will issue or cause to be issued to the e.GO Shareholders 30,000,000 Earn-Out Shares at the Closing. 20,000,000 of the Earn-Out Shares will be divided into four equal 5,000,000 share tranches, with each tranche subject to immediate vesting and release of trading and voting restrictions if the trading price per TopCo Share at any point during the trading hours of a trading day is greater than or equal to $12.50, $15.00, $20.00 and $25.00, respectively, for any 20 trading days within any period of 30 consecutive trading days during the five-year period following the Closing. The remaining 10,000,000 of such Earn-Out shares will vest immediately as of the Closing and will be subject to a 12-month lock-up.

 

On September 8, 2023, the Company entered into a fifth amendment to the Business Combination Agreement (the “Fifth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which certain terms of the Business Combination Agreement were amended to clarify the mechanics of the warrant exchange that is to occur at the closing of the Business Combination (the “Closing”), subject to the approval of Athena’s warrant holders.

 

Further, on September 11, 2023, the Company entered into a sixth amendment to the Business Combination Agreement (the “Sixth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which certain terms of the Business Combination Agreement were amended to reflect the potential for TopCo Shares to be listed on Nasdaq following the Closing.

 

16

 

 

On September 29, 2023, the Company held a special meeting of its stockholders in connection with its proposed business combination. At the special meeting, the Company’s stockholders approved (1) the business combination agreement, dated as of July 28, 2022 (as amended by the amendments to the business combination agreement, dated as of September 29, 2022, June 29, 2023, July 18, 2023, August 25, 2023, September 8, 2023, and September 11, 2023, and as may be further amended or restated from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a European company incorporated in Germany (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”) and the transactions contemplated thereby (the “Business Combination”), pursuant to which, among other things, (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the SEC guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”) (see Note 9).

 

Sponsor Letter Agreement

 

On July 28, 2022, the Company, the Sponsor, e.GO, TopCo and certain of the Company’s officers and directors (the “Athena Insiders”) entered into a Sponsor Letter Agreement, which was amended on September 29, 2022 (as it may be further amended, supplemented or otherwise modified from time to time, the “Sponsor Letter Agreement”), pursuant to which, among other things, the Sponsor and the Athena Insiders have agreed to (i) vote all of its, his or her shares of the Company’s Class A common stock to approve and adopt the Business Combination Agreement and the e.GO Transaction, (ii) waive its, his or her redemption rights with respect to its, his or her shares of the Company’s Class A common stock in connection with the e.GO Transaction, (iii) not transfer any of its, his or her shares of the Company’s Class A common stock until the Closing or termination of the Business Combination Agreement (except in limited circumstances), (iv) not transfer (a) with respect to the Sponsor, 75% of its TopCo shares and (b) with respect to all other Athena Insiders any of its, his or her TopCo ordinary shares until the date that is 180 days after the Closing (except in limited circumstances), (v) waive any adjustment to the conversion ratio set forth in the Company’s amended and restated certificate of incorporation or any other anti-dilution or similar protection with respect to the shares of the Company’s Class B common stock held by the Sponsor or the Athena Insiders, in each case, subject to the terms and conditions contemplated by the Sponsor Letter Agreement.

 

Pursuant to the Sponsor Letter Agreement, TopCo will indemnify the Sponsor from and against certain liabilities relating to the e.GO Transaction for a period of six years after the Closing and subject to an aggregate maximum indemnity of $4,000,000.

 

Forward Purchase Agreement

 

On September 29, 2022, the Company, TopCo, e.GO and Vellar Opportunity Fund SPV LLC – Series 3 (“Vellar”) entered into a Forward Purchase Agreement (the “Forward Purchase Agreement”) for an OTC equity prepaid share forward transaction (the “Forward Purchase Transaction”). Vellar agreed to waive any redemption rights with respect to any shares of the Company and shares of TopCo following the Closing of the e.GO Transaction (collectively, the “Shares”) in connection with the e.GO Transaction.

 

17

 

 

Pursuant to the terms of the Forward Purchase Agreement, Vellar intended, but was not obligated, to purchase through a broker in the open market from Public Stockholders who redeemed or indicated an intention to redeem, or from the Company, up to an aggregate amount of 15,000,000 shares of Class A common stock (the “Forward Purchase Shares”). Vellar could not beneficially own greater than 9.9% of the Shares on a post-combination pro forma basis. Upon Closing, or upon the date any assets from the Company’s Trust Account would be disbursed in connection with the e.GO Transaction, Vellar would be paid directly, out of the funds held in the Trust Account, an amount equal to (a) (i) the redemption price of shares of the Company’s Class A common stock redeemed by the Public Stockholders and purchased by Vellar, minus (ii) 10% of such amount and (b) the product of 1,500,000 multiplied by the redemption price of shares of the Company’s Class A common stock indicated to the Public Stockholders prior to the redemption deadline (as consideration for having purchased Class A common stock prior to Closing). From time to time following the Closing, Vellar, in its discretion, could sell the Forward Purchase Shares (such shares sold, the “Vellar Terminated Shares”) without payment obligation to TopCo until such time as the proceeds from the sales equal (i) 10% of the product of the number of the Forward Purchase Shares and the redemption price per share indicated to investors ahead of the Company’s redemption notice deadline or (ii) in the case of an event of default under the Bridge Financing, all amounts that are due to Vellar under such financing.

 

Upon the second anniversary of the Closing, TopCo would be obligated to pay to Vellar an amount equal to the product of (a) (x) 15,000,000 less (y) the number of Vellar Terminated Shares multiplied by (b) $2.50. Vellar could freely transfer or assign its rights under the Forward Purchase Agreement if the number of the Forward Purchase Shares it acquired would exceed 9.9% on a post-e.GO Transaction basis.

 

On March 3, 2023, the Forward Purchase Agreement was terminated.

 

Subscription Agreement

 

In connection with funding the Extension Note, the Sponsor entered into an agreement with a member of the Sponsor. Pursuant to such agreement, the Sponsor agreed to assign and transfer to such member a ratio of 1 Founder Share for every $1.5 amount funded upon the closing of the Business Combination. As of September 30, 2023, such member of the Sponsor loaned $230,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

On May 19, 2023, the Sponsor entered into an agreement with a third-party investor. Pursuant to such agreement, the Sponsor will transfer one share of Class A common stock of the Company for each dollar funded upon the closing of a Business Combination. As of September 30, 2023, such third-party investor loaned $510,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Class A Common Stock — The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 1,060,000 shares of Class A common stock issued and outstanding (excluding 181,460 and 2,048,936 shares subject to possible redemption, respectively).

 

Pursuant to the e.GO Transaction, if approved by the Company’s stockholders, at Closing, each issued and outstanding share of the Company’s Class A common stock will be automatically cancelled and extinguished and converted into one share the Surviving Company Common Stock.

 

Class B Common Stock — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 8,050,000 shares of Class B common stock outstanding.

 

Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

 

The Company’s Charter provides that the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, approximately 26.0% of the sum of the total number of all shares of common stock outstanding upon the completion of the IPO plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

 

18

 

 

Pursuant to the e.GO Transaction, if approved by the Company’s stockholders, at Closing, each issued and outstanding shares of Class B common stock will be automatically cancelled and extinguished and converted into a number of shares of Surviving Company Common Stock calculated as the sum of (x) one plus (y) the lower of (a) the total amount funded under the Bridge Financing divided by $15,000,000 and multiplied with one-fifth and (b) one-fifth, and, immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be exchanged for one TopCo Ordinary Share.

 

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. For the periods presented, there were no shares of preferred stock issued or outstanding.

 

Warrants — As of September 30, 2023 and December 31, 2022, the Company has 11,500,000 Public Warrants and 530,000 Private Placement Warrants outstanding (together, the “Warrants”). Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

 

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreements. No Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants is not effective within a specified period following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their Warrants on a cashless basis.

 

Once the Warrants become exercisable, the Company may redeem the Warrants:

 

  in whole and not in part;
     
  at a price of $0.01 per Warrant;
     
  upon not less than 30 days’ prior written notice of redemption, to each Warrant holder; and
     
  if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the Warrant holders.

 

If and when the Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares upon exercise of the Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

19

 

 

If the Company calls the Warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the Public Warrant agreement and Private Warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the Warrants will not be adjusted for issuances of shares of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless.

 

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price.

 

The Private Placement Warrants are Identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Placement Warrants and the shares of common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable at the election of the holder on a “cashless basis”.

 

Neither the Placement Warrants nor the Public Warrants contain any provision that change dependent upon the characteristics of the holder of the Warrant.

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.

 

20

 

 

At September 30, 2023 and December 31, 2022, the assets held in the Trust Account were held in treasury funds. All of the Company’s cash and investments held in the Trust Account are classified as trading securities.

 

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

       Quoted 
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
September 30, 2023 (unaudited)  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Cash and Investments held in Trust Account   1   $10,673,205   $          —   $        — 

 

       Quoted
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
December 31, 2022  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Investments held in Trust Account   1   $21,752,492   $            —   $    — 
                     
Liabilities:                    
Derivative liability – Forward Purchase Agreement   3   $   $   $1,730,000 

 

The Company utilizes a Put Model Option to value its forward purchase agreement at each reporting period, with changes in fair value recognized in the statements of operations. The estimated fair value of the forward purchase agreement liabilities is determined using Level 3 inputs. Inherent in put options pricing model are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the forward purchase agreement. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the forward purchase agreement. The expected life of the forward purchase agreement is assumed to be equivalent to their remaining contractual term. The forward purchase agreement was terminated on March 9, 2023.

 

For the three and nine months ended September 30, 2023 and 2022, there were no transfers between Levels 1, 2 or 3.

 

The following table provides quantitative information regarding Level 3 fair value measurements:

 

   December 31,
2022
 
Risk-free interest rate   4.40%
Term   2.25 
Expected volatility   78.20%
Exercise price  $2.50 
Stock price  $10.38 
Probability of transaction   50%

 

The following table presents the changes in the fair value of Forward Purchase Agreement:

 

   Forward 
   Purchase 
   Agreement 
Fair value as of September 29, 2022 (unaudited)  $1,430,000 
Change in valuation inputs or other assumptions   300,000 
Fair value as of December 31, 2022   1,730,000 
Gain on termination of derivative liability – Forward Purchase Agreement   (1,730,000)
Fair value as of September 30, 2023 (unaudited)  $ 

 

21

 

 

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheets date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than stated below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”).

 

On the Closing Date, after giving effect to the redemption of an aggregate of 784,880 shares of Athena Class A Common Stock in accordance with the terms of Athena’s Amended and Restated Certificate of Incorporation, as amended (“SPAC Redemptions”), the e.GO Shareholders receiving shares pursuant to the Business Combination Agreement own approximately 85% of the outstanding TopCo Shares, including the 20,000,000 unvested Earn-Out Shares which are approximately 21% of the outstanding TopCo Shares.

 

On November 2, 2023, the Company paid the 784,880 redeeming Class A stockholders an amount of approximately $8.67 million.

 

22

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to Athena Consumer Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Athena Consumer Acquisition Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

Athena Consumer Acquisition Corp. was incorporated in Delaware on June 4, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or other similar business transaction with one or more businesses (a “Business Combination”).

 

On July 28, 2022, the Company entered into a Business Combination Agreement (as amended by that certain first amendment to the Business Combination Agreement on September 29, 2022, and as it may be further amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a German company (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”), for the Company’s initial Business Combination (the “e.GO Transaction”). Pursuant to the Business Combination Agreement, among other things, (i) TopCo will issue to the e.GO Shareholders and convertible loan lenders of e.GO (the “Lenders”) an aggregate of up to 79,019,608 TopCo Ordinary Shares, representing aggregate consideration to the e.GO Shareholders of $800,000,000, 30,000,000 of such shares will be unvested and subject to an earn-out (the “Earn-Out Shares”), in exchange for the contribution by the e.GO Shareholders of all of the paid up no-par value shares of e.GO to TopCo and the convertible loans held by the Lenders, assuming that all e.GO Shareholders and Lender participate in the exchange; (ii) each issued and outstanding share of the Company’s Class A common stock will be automatically cancelled and extinguished and converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”), (iii) each issued and outstanding share of the Company’s Class B common stock will be automatically cancelled and extinguished and converted into a number of shares of Surviving Company Common Stock calculated as the sum of (x) one plus (y) the lower of (a) the total amount funded under the credit agreement, dated September 29, 2022, between e.GO, Brucke Funding LLC, Brucke Agent LLC and certain lenders party thereto (the “Bridge Financing”), divided by $15,000,000 and multiplied with one-fifth and (b) one-fifth; (iv) TopCo will change its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (v) Merger Sub will merge with and into the Company, with the Company being the Surviving Company and, after giving effect to the merger, becoming a direct, wholly-owned subsidiary of TopCo; (vi) each share of the Company’s common stock will be converted into one share of the Surviving Company Common Stock; (vii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one TopCo Ordinary Share; and (viii) each outstanding warrant to purchase a share of the Company’s Class A common stock will be converted into a warrant to purchase a TopCo Ordinary Share on the same contractual terms and conditions as were in effect with respect to each warrant prior to the e.GO Transaction.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”).

 

23

 

 

Results of Operations

 

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation and the initial public offering (the “IPO”). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO placed in the Trust Account (defined below). Most of the Company’s expenses for the three and nine months ended September 30, 2023 are related to the transaction described in Note 6 of the financial statements.

 

For the three months ended September 30, 2023, we had a net loss of $2,283,579, which consists of operating expenses of $2,041,634 and finance costs – discount on debt issuance of $379,608, and income tax provision of $34,017, offset by income on investments held in Trust Account of $171,680.

 

For the three months ended September 30, 2022, we had a net loss of $539,199, which consists of operating expenses of $1,271,266, change in fair value of derivative forward purchase agreement of $130,000 and income tax expense of $196,768, offset by income on investments held in Trust account of $1,058,835.

 

For the nine months ended September 30, 2023, we had a net loss of $2,141,522, which consists of operating expenses of $3,852,870, finance costs – discount on debt issuance of $562,316, and provision for income taxes of $130,141, offset by income on investments held in Trust Account of $673,805 and gain on termination of derivative liability forward purchase agreement of $1,730,000.

 

For the nine months ended September 30, 2022, we had a net loss of $1,612,841, which consists of operating expenses of $2,626,069, change in fair value of derivative forward purchase agreement of $130,000 and income tax expense of $256,026, offset by income on investments held in Trust account of $1,399,254.

 

Going Concern and Capital Resources

 

The Registration Statement on Form S-1, as amended (the “Registration Statement”), for the Company’s IPO was declared effective on October 19, 2021. On October 22, 2021, the Company consummated the IPO of 20,000,000 units (“Units”). Each Unit consists of one share of Class A common stock (the “Public Shares”) and one-half of a redeemable warrant (each, a “Public Warrant”). The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 3.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 1,000,000 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Athena Consumer Acquisition Sponsor LLC (the “Sponsor”) generating gross proceeds of $10,000,000, which is described in Note 4.

 

Simultaneously with the closing of the IPO, the Company consummated the closing of the sale of 3,000,000 additional Units upon receiving notice of the underwriter’s election to fully exercise its over-allotment option (“Overallotment Units”), generating additional gross proceeds of $30,000,000. Simultaneously with the exercise of the over-allotment, the Company consummated the Private Placement of an additional 60,000 Private Placement Units to the Sponsor, generating gross proceeds of $600,000.

 

Following the closing of the IPO and exercise of the over-allotment, $234,600,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.

 

For the nine months ended September 30, 2023, $1,519,240 of cash was used in operating activities. Net loss of $2,141,522 was offset by a non-cash charge for the gain on termination of derivative liability forward purchase agreement of $1,730,000, interest earned on investments held in Trust Account of $673,805, finance costs – discount on debt issuance of $562,316. Changes in operating assets and liabilities provided $2,463,771 of cash from operating activities.

 

For the nine months ended September 30, 2022, $689,968 of cash was used in operating activities. Net loss of $1,612,841 was offset by interest earned on investments held in Trust Account of $1,399,254, deferred tax asset of $15,299 and change in fair value of derivative liability of forward purchase activity of $130,000. Changes in operating assets and liabilities provided $2,176,828 of cash from operating activities.

 

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

24

 

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2023, there was approximately $1,414,717 outstanding under the Working Capital Loans..

 

On October 19, 2023, as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management believes that the liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2023. We do not participate in transactions that create relationships with entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. The underwriter was entitled to deferred underwriting commissions of $8,650,000 consisting of the $8,050,000 deferred portion and the $600,000 cash discount agreed to be deferred until Business Combination. The deferred fee would become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On December 8, 2022, Citigroup Global Markets Inc. (“Citi”), as representative of the underwriters, agreed to formally waive the deferred underwriting commissions of $8,650,000 in full, pursuant to a deferred fee waiver letter agreement between Citi and the Company only upon the successful Business Combination under the e.GO Transaction.

 

The Company also agreed, commencing on October 19, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space and administrative support services.

 

Critical Accounting Policies and Estimates

 

The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies and estimates:

 

25

 

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

 

Derivative Liabilities

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has determined forward purchase agreements are derivative instruments.

 

Income Taxes

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. 

 

Common Stock Subject to Possible Redemption

 

We account for our common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our balance sheets. We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Immediately upon the closing of the IPO, we recognized the accretion from initial book value to redemption amount value. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

 

26

 

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a “smaller reporting company,” we are not required to provide the information called for by this Item.

 

Item 4. Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

 

Changes in Internal Control Over Financial Reporting

 

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

27

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our annual report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 30, 2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our annual report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 30, 2023, considered that the initial Business Combination with e.GO, TopCo and Merger Sub was consummated on October 19, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The securities sold in the IPO were registered under the Securities Act on a registration statement on Form S-1 (Registration No. 333-258050). The Registration Statement for the Company’s IPO was declared effective on October 19, 2021. On October 22, 2021, the Company consummated the IPO of 20,000,000 Units. Each Unit consists of one Public Shares and one-half of a Public Warrant. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $200,000,000, which is discussed in Note 3.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 1,000,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Company’s Sponsor, generating gross proceeds of $10,000,000. Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $13,116,818, consisting of $4,000,000 of underwriting fees, $8,650,000 of deferred underwriting fees payable (which are held in the Trust Account) and $466,818 of other costs. As described in Note 6, the $8,650,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement.

 

Simultaneously with the closing of the IPO, the Company consummated the closing of the sale of 3,000,000 Overallotment Units upon receiving notice of the underwriter’s election to fully exercise its over-allotment option, generating additional gross proceeds of $30,000,000. Simultaneously with the exercise of the over-allotment, the Company consummated the Private Placement of an additional 60,000 Private Placement Units to the Sponsor, generating gross proceeds of $600,000.

 

Following the closing of the IPO and exercise of the over-allotment, $234,600,000 from the net proceeds of the sale of the Units in the IPO and the Private Placement Units, including the amounts generated from the exercise of the underwriters’ over-allotment option, was placed in the Trust Account and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.

 

We paid a total of $4,000,000 underwriting discounts and commissions and $466,818 for other offering costs and expenses related to the IPO. In addition, the underwriters agreed to defer $8,650,000 in underwriting discounts and commissions. On December 8, 2002, Citi, as representative of the underwriters, agreed to formally waive the deferred underwriting commissions of $8,650,000 in full, pursuant to a deferred fee waiver letter agreement between Citi and the Company.

 

For a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this Quarterly Report.

 

28

 

 

The Company’s Charter provided the Company the right to extend the Deadline Date six times for an additional one month each time, from January 22, 2023, the initial Deadline Date, to up to July 22, 2023. The Company’s Board implemented the six Extensions and extended the Deadline Date to July 22, 2023. On July 19, 2023, the Company held the Second Extension Meeting. At the Second Extension Meeting, the Company’s stockholders approved (1) the Second Extension Amendment Proposal to provide the Company with the right to extend the Deadline Date up to three times for an additional one month each time, from July 22, 2023 to up to October 22, 2023 and (2) the Redemption Limitation Amendment Proposal. In connection with the Second Extension Meeting, a total of 1,082,596 shares of the Company’s Class A common stock were presented for redemption. As a result, there was approximately $10.48 million remaining in the Trust Account as of July 28, 2023 following redemptions. On July 20, 2023, the Sponsor initiated the wire of the $60,000 to the Company’s Trust Account in connection with the extension of the Deadline Date to August 22, 2023 following the Second Extension Meeting. The Company’s Board implemented all three of the Second Extensions and extended the Deadline Date to October 22, 2023. In connection with the implementation of the six Extensions and the three Second Extensions, the Sponsor deposited an aggregate of $856,149 as contributions into the Trust Account.

 

On August 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from August 22, 2023 for an additional month to September 22, 2023, the second of three potential one-month extensions of the Deadline Date available to the Company. On August 21, 2023, the Sponsor deposited $60,000 into the Company’s trust account in connection with the second Extension.

 

On September 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from September 22, 2023 for an additional month to October 22, 2023, the last of three potential one-month extensions of the Deadline Date available to the Company. On September 21, 2023, the Sponsor deposited $60,000 into the Company’s trust account in connection with the third Extension.

 

On September 29, 2023, the Company held a special meeting of its stockholders in connection with its proposed business combination. At the special meeting, the Company’s stockholders approved (1) the business combination agreement, dated as of July 28, 2022 (as amended by the amendments to the business combination agreement, dated as of September 29, 2022, June 29, 2023, July 18, 2023, August 25, 2023, September 8, 2023, and September 11, 2023, and as may be further amended or restated from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a European company incorporated in Germany (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”) and the transactions contemplated thereby (the “Business Combination”), pursuant to which, among other things, (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the SEC guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions.

 

On October 10, 2023, the Company called a special meeting of its stockholders for October 20, 2023 (the “Third Extension Meeting”) to approve a proposed amendment to the Company’s Charter to further extend the Deadline Date. Because the e.GO Transaction was consummated on October 19, 2023, as discussed below, the Company determined that the Third Extension Meeting was no longer necessary, and therefore determined to cancel the Third Extension Meeting.

 

On October 19, 2023, we consummated the e.GO Transaction. On the Closing Date of the e.GO Transaction, (i) TopCo issued to the e.GO Shareholders an aggregate of up to 79,019,608 newly issued TopCo Shares inclusive of 30,000,000 Earn-Out Shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up; (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the Surviving Company, and in connection with the Merger, each share of the Company’s Class A common stock and each issued and outstanding share of the Company’s Class B common stock was converted into one share of Surviving Company Common Stock; (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) the Warrant Exchange was effectuated. A total of 784,880 shares of the Company’s Class A common stock were presented for redemption in connection with the Special Meeting and the amount paid out to redeem such shares was approximately $8,673,955 from the Trust Account..

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

29

 

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
2.1   Business Combination Agreement, dated as of July 28, 2022, by and among Athena Consumer Acquisition Corp., Next.e.GO Mobile SE, Next.e.GO B.V. and Time is Now Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 28, 2022).
2.2   First Amendment to Business Combination Agreement, dated as of September 29, 2022, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on October 3, 2022).
2.3   Second Amendment to Business Combination Agreement, dated as of June 29, 2023, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 6, 2023).
2.4   Third Amendment to Business Combination Agreement, dated as of July 18, 2023, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 19, 2023).
2.5   Fourth Amendment to Business Combination Agreement, dated as of August 25, 2023, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on August 28, 2023).
2.6   Fifth Amendment to Business Combination Agreement, dated as of September 8, 2023, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on September 8, 2023).
2.7   Sixth Amendment to Business Combination Agreement, dated as of September 11, 2023, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on September 8, 2023).
10.1   Sponsor Letter Agreement, dated as of July 28, 2022, by and among Athena Consumer Acquisition Corp., Athena Consumer Acquisition Sponsor LLC, Next.e.GO Mobile SE, Next.e.GO B.V. and certain individuals party thereto (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 28, 2022).
10.2   First Amendment to Sponsor Letter Agreement, dated as of September 29, 2022, by and between Athena Consumer Acquisition Corp. and Next.e.GO Mobile SE (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on October 3, 2022).
10.3   Extension Promissory Note, dated as of January 17, 2023, between Athena Consumer Acquisition Corp. and Athena Consumer Acquisition Sponsor LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on January 17, 2023).
10.4   Working Capital Promissory Note, dated as of January 17, 2023, between Athena Consumer Acquisition Corp. and Athena Consumer Acquisition Sponsor LLC (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on January 17, 2023).
10.5   Amended and Restated Working Capital Promissory Note, dated as of May 19, 2023, between Athena Consumer Acquisition Corp. and Athena Consumer Acquisition Sponsor LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on May 22, 2023).
10.6   Second Amended and Restated Working Capital Promissory Note, dated as of July 7, 2023, between Athena Consumer Acquisition Corp. and Athena Consumer Acquisition Sponsor LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 10, 2023).
10.7   Second Extension Promissory Note, dated as of July 20, 2023, between Athena Consumer Acquisition Corp. and Athena Consumer Acquisition Sponsor LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-40921), filed with the Securities and Exchange Commission on July 21, 2023).
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

30

 

 

SIGNATURE

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ATHENA CONSUMER ACQUISITION CORP.
   
Date: November 20, 2023 By: /s/ Angelina Smith
  Name:  Angelina Smith
  Title: Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

 

31

 

 

 

0.02 0.05 0.20 0.22 0.02 0.05 0.20 0.22 0.02 0.02 0.22 0.22 0.05 0.05 0.20 0.20 false --12-31 Q3 10018 0001869141 0001869141 2023-01-01 2023-09-30 0001869141 acaq:UnitsEachConsistingOfOneShareOfClassACommonStockParValue00001PerShareAndOnehalfOfOneRedeemableWarrantMember 2023-01-01 2023-09-30 0001869141 acaq:SharesOfClassACommonStockParValue00001PerShareIncludedAsPartOfTheUnitsMember 2023-01-01 2023-09-30 0001869141 acaq:RedeemableWarrantsIncludedAsPartOfTheUnitsMember 2023-01-01 2023-09-30 0001869141 us-gaap:CommonClassAMember 2023-11-14 0001869141 us-gaap:CommonClassBMember 2023-11-14 0001869141 2023-09-30 0001869141 2022-12-31 0001869141 us-gaap:RelatedPartyMember 2023-09-30 0001869141 us-gaap:RelatedPartyMember 2022-12-31 0001869141 us-gaap:CommonClassAMember 2023-09-30 0001869141 us-gaap:CommonClassAMember 2022-12-31 0001869141 us-gaap:CommonClassBMember 2023-09-30 0001869141 us-gaap:CommonClassBMember 2022-12-31 0001869141 2023-07-01 2023-09-30 0001869141 2022-07-01 2022-09-30 0001869141 2022-01-01 2022-09-30 0001869141 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001869141 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001869141 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001869141 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001869141 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001869141 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001869141 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001869141 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001869141 us-gaap:RetainedEarningsMember 2022-12-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001869141 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001869141 2023-01-01 2023-03-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001869141 us-gaap:RetainedEarningsMember 2023-03-31 0001869141 2023-03-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001869141 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001869141 2023-04-01 2023-06-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001869141 us-gaap:RetainedEarningsMember 2023-06-30 0001869141 2023-06-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001869141 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001869141 us-gaap:RetainedEarningsMember 2023-09-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001869141 us-gaap:RetainedEarningsMember 2021-12-31 0001869141 2021-12-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001869141 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001869141 2022-01-01 2022-03-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001869141 us-gaap:RetainedEarningsMember 2022-03-31 0001869141 2022-03-31 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001869141 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001869141 2022-04-01 2022-06-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001869141 us-gaap:RetainedEarningsMember 2022-06-30 0001869141 2022-06-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001869141 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001869141 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001869141 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001869141 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001869141 us-gaap:RetainedEarningsMember 2022-09-30 0001869141 2022-09-30 0001869141 us-gaap:IPOMember 2021-10-22 2021-10-22 0001869141 us-gaap:IPOMember 2021-10-22 0001869141 us-gaap:IPOMember 2021-10-02 2021-10-22 0001869141 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001869141 us-gaap:PrivatePlacementMember 2023-09-30 0001869141 acaq:BusinessCombinationMember 2023-01-01 2023-09-30 0001869141 us-gaap:IPOMember 2023-01-01 2023-09-30 0001869141 us-gaap:IPOMember 2023-09-30 0001869141 2023-01-01 2023-01-17 0001869141 2023-01-23 0001869141 2023-01-30 0001869141 2023-01-01 2023-01-30 0001869141 2023-02-01 2023-02-17 0001869141 2023-02-17 0001869141 2023-03-01 2023-03-20 0001869141 2023-03-21 0001869141 2023-04-01 2023-04-18 0001869141 2023-04-20 0001869141 2023-05-01 2023-05-19 0001869141 2023-05-22 0001869141 2023-06-01 2023-06-20 0001869141 2023-06-21 0001869141 2023-07-28 0001869141 2023-07-20 0001869141 acaq:SponsorMember 2023-07-01 2023-07-20 0001869141 2023-07-01 2023-07-21 0001869141 2023-08-01 2023-08-18 0001869141 2023-08-18 0001869141 2023-09-01 2023-09-15 0001869141 2023-09-21 0001869141 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-09-30 0001869141 us-gaap:CommonClassAMember 2023-09-29 0001869141 2022-08-01 2022-08-16 0001869141 acaq:FairMarketMember 2023-08-01 2023-08-16 0001869141 2023-06-01 2023-06-19 0001869141 2023-06-19 0001869141 us-gaap:FranchiseMember acaq:CapitalResourcesMember 2023-09-30 0001869141 acaq:CapitalResourcesMember 2023-09-30 0001869141 acaq:CapitalResourcesMember 2023-01-01 2023-09-30 0001869141 acaq:InvestmentsHeldInTrustAccountMember 2023-09-30 0001869141 2022-01-01 2022-12-31 0001869141 2021-01-01 2021-12-31 0001869141 us-gaap:OverAllotmentOptionMember 2023-09-30 0001869141 us-gaap:PrivatePlacementMember 2021-10-01 2021-10-22 0001869141 us-gaap:PrivatePlacementMember 2021-10-22 0001869141 us-gaap:PrivatePlacementMember 2021-10-22 2021-10-22 0001869141 acaq:SponsorMember us-gaap:CommonClassBMember 2021-06-04 0001869141 2021-06-01 2021-06-24 0001869141 2021-09-01 2021-09-23 0001869141 acaq:FounderSharesMember 2023-01-01 2023-09-30 0001869141 srt:MaximumMember 2023-01-01 2023-09-30 0001869141 srt:MinimumMember 2023-01-01 2023-09-30 0001869141 acaq:PromissoryNoteMember 2021-06-01 2021-06-04 0001869141 2021-10-22 0001869141 us-gaap:PrivatePlacementMember 2023-09-30 0001869141 acaq:PromissoryNoteMember 2023-01-01 2023-01-17 0001869141 acaq:SponsorMember 2023-01-01 2023-01-17 0001869141 2023-07-01 2023-07-07 0001869141 acaq:PromissoryNoteMember 2023-01-01 2023-09-30 0001869141 2023-07-20 2023-07-20 0001869141 acaq:SponsorMember 2023-01-01 2023-09-30 0001869141 acaq:RelatedPartyLoansMember acaq:SponsorMember 2023-09-30 0001869141 acaq:SponsorMember 2023-09-30 0001869141 us-gaap:OverAllotmentOptionMember 2021-10-22 2021-10-22 0001869141 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001869141 2022-12-01 2022-12-08 0001869141 acaq:TopcoMember 2022-07-28 0001869141 2022-07-28 2022-07-28 0001869141 us-gaap:CommonClassAMember 2022-07-28 2022-07-28 0001869141 2022-07-28 0001869141 acaq:BridgeFinancingMember 2022-07-28 2022-07-28 0001869141 us-gaap:CommonStockMember 2022-07-28 2022-07-28 0001869141 acaq:SecondAmendmentToTheBusinessCombinationAgreementMember 2023-01-01 2023-09-30 0001869141 us-gaap:WarrantMember us-gaap:CommonClassAMember 2023-09-30 0001869141 us-gaap:WarrantMember 2023-09-30 0001869141 srt:MaximumMember us-gaap:WarrantMember acaq:TopcoMember 2023-09-30 0001869141 srt:MinimumMember us-gaap:WarrantMember acaq:TopcoMember 2023-09-30 0001869141 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-09-30 0001869141 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-30 0001869141 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-09-30 0001869141 acaq:ShareBasedCompensationAwardTrancheFourMember 2023-09-30 0001869141 us-gaap:CommonStockMember 2023-09-29 0001869141 us-gaap:CommonStockMember 2023-09-29 2023-09-29 0001869141 us-gaap:CommonStockMember acaq:TopcoMember 2023-09-29 0001869141 2023-09-29 0001869141 us-gaap:SubsequentEventMember 2023-10-19 0001869141 srt:MaximumMember 2023-10-19 0001869141 srt:MinimumMember 2023-10-19 0001869141 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2023-10-19 0001869141 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2023-10-19 0001869141 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-10-19 2023-10-19 0001869141 us-gaap:SubsequentEventMember 2023-10-19 2023-10-19 0001869141 us-gaap:WarrantMember acaq:TopcoMember us-gaap:SubsequentEventMember 2023-10-19 0001869141 acaq:SponsorMember 2022-07-28 2022-07-28 0001869141 acaq:ForwardPurchaseAgreementMember us-gaap:CommonClassAMember 2023-09-30 0001869141 acaq:ForwardPurchaseAgreementMember 2023-01-01 2023-09-30 0001869141 acaq:TopcoMember 2023-09-30 0001869141 acaq:FounderSharesMember 2023-09-30 0001869141 acaq:SubscriptionAgreementMember 2023-01-01 2023-09-30 0001869141 us-gaap:CommonClassAMember 2023-05-19 0001869141 acaq:PublicWarrantsMember 2023-09-30 0001869141 acaq:PrivatePlacementWarrantsMember 2023-09-30 0001869141 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001869141 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001869141 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001869141 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001869141 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001869141 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001869141 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001869141 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001869141 2022-09-28 0001869141 2022-09-29 2022-12-31 0001869141 us-gaap:SubsequentEventMember 2023-10-01 2023-10-19 0001869141 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-10-19 0001869141 us-gaap:SubsequentEventMember 2023-11-02 2023-11-02 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR xbrli:shares

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jane Park, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Athena Consumer Acquisition Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the periods in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 20, 2023

 

  By: /s/ Jane Park
  Name: Jane Park
  Title: Chief Executive Officer
(Principal Executive Officer)

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Angelina Smith, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Athena Consumer Acquisition Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the periods in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 20, 2023

 

  By: /s/ Angelina Smith
  Name: Angelina Smith
  Title: Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report on Form 10-Q of Athena Consumer Acquisition Corp. (the “Company”) for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Jane Park, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 20, 2023

 

  By: /s/ Jane Park
  Name: Jane Park
  Title: Chief Executive Officer
(Principal Executive Officer)

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Athena Consumer Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Angelina Smith, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: November 20, 2023

 

  By: /s/ Angelina Smith
  Name:  Angelina Smith
  Title: Chief Financial Officer
(Principal Financial and Accounting Officer)

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Document Information Line Items    
Entity Registrant Name ATHENA CONSUMER ACQUISITION CORP.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001869141  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40921  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 87-1178222  
Entity Address, Address Line One 442 5th Avenue  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
City Area Code (970)  
Local Phone Number 925-1572  
Entity Interactive Data Current Yes  
Entity Address, Postal Zip Code 10018  
Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and one-half of one redeemable warrant    
Document Information Line Items    
Trading Symbol ACAQ.U  
Title of 12(b) Security Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and one-half of one redeemable warrant  
Security Exchange Name NYSEAMER  
Shares of Class A common stock, par value $0.0001 per share, included as part of the units    
Document Information Line Items    
Trading Symbol ACAQ  
Title of 12(b) Security Shares of Class A common stock, par value $0.0001 per share, included as part of the units  
Security Exchange Name NYSEAMER  
Redeemable warrants included as part of the units    
Document Information Line Items    
Trading Symbol ACAQ WS  
Title of 12(b) Security Redeemable warrants included as part of the units  
Security Exchange Name NYSEAMER  
Class A Common Stock    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   0
Class B Common Stock    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   0
v3.23.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash $ 8,536 $ 13,612
Cash – restricted 17,864
Prepaid expenses and other assets 40,501 261,230
Cash held in Trust Account for redeemed shares 8,668,990
Prepaid income taxes 59,926
Total current assets 8,795,817 274,842
Cash and Investments held in Trust Account 2,004,215 21,752,492
TOTAL ASSETS 10,800,032 22,027,334
CURRENT LIABILITIES    
Accounts payable and accrued expenses 6,240,443 3,304,154
Income tax payable 674,933
Franchise tax payable 17,864 58,857
Excise tax payable 203,048
Due to redeeming Stockholders 8,668,990
Total current liabilities 16,627,667 4,037,944
Derivative liability – Forward Purchase Agreement 1,730,000
Deferred underwriting fee payable 8,650,000 8,650,000
TOTAL LIABILITIES 25,277,667 14,417,944
COMMITMENTS AND CONTINGENCIES
COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION    
Class A common stock subject to possible redemption, $0.0001 par value, 181,460 and 2,048,936 shares at redemption value of $11.02 and $10.28 per share at September 30, 2023 and December 31, 2022, respectively 1,999,598 21,061,039
STOCKHOLDERS’ DEFICIT    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at September 30, 2023 and December 31, 2022
Class A common stock; $0.0001 par value; 100,000,000 shares authorized; 1,060,000 shares issued and outstanding (excluding 181,460 and 2,048,936 shares subject to possible redemption) at September 30, 2023 and December 31, 2022 106 106
Class B common stock; $0.0001 par value; 10,000,000 shares authorized; 8,050,000 shares issued and outstanding at September 30, 2023 and December 31, 2022 805 805
Additional paid-in capital 359,268
Accumulated deficit (16,837,412) (13,452,560)
TOTAL STOCKHOLDERS’ DEFICIT (16,477,233) (13,451,649)
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT 10,800,032 22,027,334
Related Party    
CURRENT LIABILITIES    
Due to related parties 82,605  
Promissory note - related party, net of discount $ 1,414,717
v3.23.3
Condensed Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock    
Common stock subject to possible redemption, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock subject to possible redemption, redemption value 181,460 2,048,936
Common stock subject to possible redemption, redemption value per share (in Dollars per share) $ 11.02 $ 10.28
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 1,060,000 1,060,000
Common stock, shares outstanding 1,060,000 1,060,000
Class B Common Stock    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 10,000,000 10,000,000
Common stock, shares issued 8,050,000 8,050,000
Common stock, shares outstanding 8,050,000 8,050,000
v3.23.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
OPERATING EXPENSES        
General and administrative $ 2,041,634 $ 1,271,266 $ 3,852,870 $ 2,626,069
Total operating expenses (2,041,634) (1,271,266) (3,852,870) (2,626,069)
OTHER INCOME (EXPENSES)        
Income on investments held in Trust Account 171,680 1,058,835 673,805 1,399,254
Finance costs – discount on debt issuance (379,608) (562,316)
Gain on termination of Derivative liability – Forward Purchase Agreement (130,000) 1,730,000 (130,000)
Total other income (expense), net (207,928) 928,835 1,841,489 1,269,254
LOSS BEFORE PROVISION FOR INCOME TAXES (2,249,562) (342,431) (2,011,381) (1,356,815)
Provision for income taxes (34,017) (196,768) (130,141) (256,026)
Net loss $ (2,283,579) $ (539,199) $ (2,141,522) $ (1,612,841)
Class A Common Stock        
OTHER INCOME (EXPENSES)        
Weighted average shares outstanding (in Shares) 2,241,388 24,060,000 2,816,576 24,060,000
Basic net loss per share (in Dollars per share) $ (0.22) $ (0.02) $ (0.2) $ (0.05)
Class B Common Stock        
OTHER INCOME (EXPENSES)        
Weighted average shares outstanding (in Shares) 8,050,000 8,050,000 8,050,000 8,050,000
Basic net loss per share (in Dollars per share) $ (0.22) $ (0.02) $ (0.2) $ (0.05)
v3.23.3
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Common Stock        
Diluted net loss per share $ (0.22) $ (0.02) $ (0.20) $ (0.05)
Class B Common Stock        
Diluted net loss per share $ (0.22) $ (0.02) $ (0.20) $ (0.05)
v3.23.3
Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)
Class A
Common Stock
Class B
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 106 $ 805 $ (7,310,530) $ (7,309,619)
Balance (in Shares) at Dec. 31, 2021 1,060,000 8,050,000      
Net income (loss) (222,314) (222,314)
Balance at Mar. 31, 2022 $ 106 $ 805 (7,532,844) (7,531,933)
Balance (in Shares) at Mar. 31, 2022 1,060,000 8,050,000      
Balance at Dec. 31, 2021 $ 106 $ 805 (7,310,530) (7,309,619)
Balance (in Shares) at Dec. 31, 2021 1,060,000 8,050,000      
Net income (loss)         (1,612,841)
Balance at Sep. 30, 2022 $ 106 $ 805 (11,354,590) (11,353,679)
Balance (in Shares) at Sep. 30, 2022 1,060,000 8,050,000      
Balance at Mar. 31, 2022 $ 106 $ 805 (7,532,844) (7,531,933)
Balance (in Shares) at Mar. 31, 2022 1,060,000 8,050,000      
Net income (loss) (851,328) (851,328)
Balance at Jun. 30, 2022 $ 106 $ 805 (8,384,172) (8,383,261)
Balance (in Shares) at Jun. 30, 2022 1,060,000 8,050,000      
Remeasurement of Class A common stock subject to possible redemption (1,001,219) (1,001,219)
Initial value of Derivative Liability – Forward Purchase Agreement (1,430,000) (1,430,000)
Net income (loss) (539,199) (539,199)
Balance at Sep. 30, 2022 $ 106 $ 805 (11,354,590) (11,353,679)
Balance (in Shares) at Sep. 30, 2022 1,060,000 8,050,000      
Balance at Dec. 31, 2022 $ 106 $ 805 (13,452,560) (13,451,649)
Balance (in Shares) at Dec. 31, 2022 1,060,000 8,050,000      
Remeasurement of Class A common stock subject to possible redemption (470,123) (470,123)
Class B common stock to be transferred to fund promissory note 79,805 79,805
Net income (loss) 838,087 838,087
Balance at Mar. 31, 2023 $ 106 $ 805 79,805 (13,084,596) (13,003,880)
Balance (in Shares) at Mar. 31, 2023 1,060,000 8,050,000      
Balance at Dec. 31, 2022 $ 106 $ 805 (13,452,560) (13,451,649)
Balance (in Shares) at Dec. 31, 2022 1,060,000 8,050,000      
Net income (loss)         (2,141,522)
Balance at Sep. 30, 2023 $ 106 $ 805 359,268 (16,837,412) (16,477,233)
Balance (in Shares) at Sep. 30, 2023 1,060,000 8,050,000      
Balance at Mar. 31, 2023 $ 106 $ 805 79,805 (13,084,596) (13,003,880)
Balance (in Shares) at Mar. 31, 2023 1,060,000 8,050,000      
Remeasurement of Class A common stock subject to possible redemption (431,247) (431,247)
Class B common stock to be transferred to fund promissory note 79,805 79,805
Class A common stock to be transferred to fund promissory note 247,836 247,836
Net income (loss) (696,030) (696,030)
Balance at Jun. 30, 2023 $ 106 $ 805 407,446 (14,211,873) (13,803,516)
Balance (in Shares) at Jun. 30, 2023 1,060,000 8,050,000      
Remeasurement of Class A common stock subject to possible redemption (341,960) (341,960)
Class B common stock to be transferred to fund promissory note     3,269 3,269
Excise tax payable attributable to redemption of Class A common stock (203,048) (203,048)
Class A common stock to be transferred to fund promissory note 151,601 151,601
Net income (loss) (2,283,579) (2,283,579)
Balance at Sep. 30, 2023 $ 106 $ 805 $ 359,268 $ (16,837,412) $ (16,477,233)
Balance (in Shares) at Sep. 30, 2023 1,060,000 8,050,000      
v3.23.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (2,141,522) $ (1,612,841)
Adjustments to reconcile net loss to net cash used in operating activities:    
Finance costs – discount on debt issuance 562,316
Income on investments held in Trust Account (673,805) (1,399,254)
Deferred tax asset 15,299
Gain on termination of Derivative liability – Forward Purchase Agreement (1,730,000) 130,000
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 160,803 198,400
Accounts payable and accrued expenses 2,936,289 1,687,213
Due to related parties 82,605  
Income tax and Franchise tax payable (715,926) 291,215
Net cash used in operating activities (1,519,240) (689,968)
CASH FLOWS FROM INVESTING ACTIVITIES    
Principal deposited in Trust Account (860,766)
Cash withdrawn from trust in connection with redemption 11,635,781
Withdrawal from Trust Account for payment of income and franchise taxes 978,077 98,622
Net cash provided by investing activities 11,753,092 98,622
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from Sponsor loans 1,414,717
Payments for redemptions of Class A common stock (11,635,781)
Net cash used in financing activities (10,221,064)
Net change in cash 12,788 (591,346)
Cash, beginning of period 13,612 850,615
Cash, end of period 26,400 259,269
Cash, end of period-restricted to pay franchise tax payable 17,864
Cash, end of period-unrestricted 8,536 259,269
TOTAL 26,400 259,269
Cash paid for income taxes 865,000  
Class B Common Stock to be transferred to fund promissory note 162,879
Class A Common Stock to be transferred to fund promissory note 399,437
Initial value of derivative liability – Forward Purchase Agreement $ 1,430,000
v3.23.3
Description of Organization and Business Operations
9 Months Ended
Sep. 30, 2023
Description of Organization and Business Operations [Abstract]  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Athena Consumer Acquisition Corp. (the “Company”) was incorporated in Delaware on June 4, 2021. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business Combination”).

 

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023, relates to the Company’s formation and Initial Public Offering (“IPO”), which is described below and, since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO.

 

The registration statement for the Company’s IPO was declared effective on October 19, 2021. On October 22, 2021, the Company consummated the IPO and overallotment option of 23,000,000 units (“Units”) with respect to the Class A common stock included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $230,000,000, which is discussed in Note 3.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 1,060,000 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Athena Consumer Acquisition Sponsor LLC (the “Sponsor”) generating gross proceeds of $10,600,000, which is described in Note 4.

 

Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $13,116,818, consisting of $4,000,000 of underwriting fees, $8,650,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $466,818 of other costs. As described in Note 6, the $8,650,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement.

 

Following the closing of the IPO and exercise of the over-allotment, $234,600,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a Trust Account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo.

 

On December 16, 2022, the Company issued a press release announcing that, in connection with a special meeting of stockholders (the “Extension Meeting”) to be held for the purpose of considering and voting on, among other proposals, a proposal to amend the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) to provide the Company with the right to extend the date (the “Deadline Date”) by which it must consummate an initial business combination (the “Extension”) up to six times for an additional one month each time, from January 22, 2023 to up to July 22, 2023, if the Extension Amendment is approved at the Extension Meeting and an Extension is implemented, the Sponsor, or its designees will deposit into the Trust Account as a loan (a “Contribution”, and the Sponsor or its designee making such Contribution, a “Contributor”), the lesser of (x) $121,000 or (y) $0.055 per public share multiplied by the number of public shares outstanding, on each of the following dates: (i) January 23, 2023; and (ii) one business day following the public announcement by the Company disclosing that the Company’s board of directors (the “Board”) has determined to extend the Deadline Date for an additional month in accordance with the Extension (each date on which a Contribution is to be deposited into the Trust Account, a “Contribution Date”).

 

On December 21, 2022, the Company held the Extension Meeting. At the Extension Meeting, the Company’s stockholders approved the Extension Amendment, providing the Company with the right to extend the Deadline Date up to six times for an additional one month each time, from January 22, 2023 (the date which is 15 months from the closing date of the Company’s IPO) to up to July 22, 2023 (the date which is 21 months from the closing date of the IPO).

 

On January 17, 2023, the Board determined to implement a first Extension and to extend the Deadline Date for an additional month to February 22, 2023. On the same date, in connection with the Extension and pursuant to an unsecured promissory note the Company and the Sponsor entered into on January 17, 2023 (the “Extension Note”), the Board delivered to the Sponsor a written request to draw down $112,691 for the first month of the Extension. Upon this written request, the Sponsor deposited the $112,691 to the Company’s Trust Account on January 23, 2023.

 

On January 30, 2023, the Company received notifications via phone calls from the staff of the New York Stock Exchange (the “NYSE”) that it had determined that the Company was not in compliance with the requirements of Section 802.01B of the NYSE Listed Company Manual (the “LCM”), which requires a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly held shares (a “public float”) over a consecutive 30 trading day period of at least $40,000,000.

 

On February 9, 2023, the Company issued a press release announcing that it would transfer its listing to the NYSE American LLC (the “NYSE American”). The Company received written confirmation that it had been cleared to file an initial listing application with the NYSE American on February 6, 2023, and received the final approval for listing from the staff of the NYSE American on February 9, 2023. In connection with listing on the NYSE American, the Company would voluntarily delist from the New York Stock Exchange. Following the transfer of its listing, the Company intends to continue to file the same periodic reports and other information it currently files with the Securities and Exchange Commission. On February 14, 2023, the Company voluntarily delisted its securities from the NYSE and the Company’s securities commenced trading on the NYSE American under the same symbols.

 

On February 17, 2023, the Board determined to implement a second Extension to allow additional time for the Company to complete its initial business combination. In connection with the second Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the second month of the Extension. On the same day, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the second Extension.

 

On March 20, 2023, the Board determined to implement a third Extension to allow additional time for the Company to complete its initial business combination. In connection with the third Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the third month of the Extension. On March 21, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the third Extension.

 

On April 18, 2023, the Board determined to implement a fourth Extension to allow additional time for the Company to complete its initial business combination. In connection with the fourth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the fourth month of the Extension. On April 20, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the fourth Extension.

 

On April 20, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from April 22, 2023 for an additional month to May 22, 2023, the fourth of six potential one-month extensions of the Deadline Date available to the Company.

 

On May 19, 2023, the Board determined to implement a fifth Extension to allow additional time for the Company to complete its initial business combination. In connection with the fifth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the fifth month of the Extension. On May 22, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the fifth Extension.

 

On May 22, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from May 22, 2023 for an additional month to June 22, 2023, the fifth of six potential one-month extensions of the Deadline Date available to the Company then.

 

On June 20, 2023, the Board determined to implement a sixth Extension to allow additional time for the Company to complete its initial business combination. In connection with the sixth Extension and pursuant to the Extension Note, the Board delivered to the Sponsor a written request to draw down $112,691 for the sixth month of the Extension. On June 21, 2023, the Sponsor deposited $112,691 into the Company’s Trust Account in connection with the sixth Extension.

 

On June 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from June 22, 2023 for an additional month to July 22, 2023, the last of six potential one-month extensions of the Deadline Date available to the Company then.

 

On July 19, 2023, the Company held a special meeting of its stockholders (the “Second Extension Meeting”). At the Second Extension Meeting, the Company’s stockholders approved (1) a proposal to amend the Company’s amended and restated certificate of incorporation, as amended on December 21, 2022 (the proposed amendment, the “Second Extension Amendment”) to provide the Company with the right to extend the Deadline Date up to three times for an additional one month each time (the “Second Extension”), from July 22, 2023 (the date which is 21 months from the closing date of the IPO) to up to October 22, 2023 (the date which is 24 months from the closing date of the IPO) (the “Second Extension Amendment Proposal”) and (2) a proposal to amend the Company’s amended and restated certificate of incorporation, as amended on December 21, 2022 (the “Redemption Limitation Amendment”, together with the Second Extension Amendment, the “Charter Amendment”) to eliminate (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 (the “Redemption Limitation Amendment Proposal”). The Sponsor, has agreed that if the Second Extension Amendment is implemented, the Sponsor or its designees will deposit into the Trust Account as a loan of $60,000 (the “Second Contribution”) on each of the following dates: (i) July 20, 2023; and (ii) one business day following the public announcement by the Company disclosing that its board of directors has determined to extend the Deadline Date for an additional month in accordance with the Second Extension Amendment.

 

A total of 1,082,596 shares of the Company’s Class A common stock was presented for redemption in connection with the Second Extension Meeting. As a result, there is approximately $10.48 million remaining in the Trust Account as of July 28, 2023 following redemptions.

 

On July 19, 2023, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware.

 

In connection with the Second Contribution, on July 20, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $180,000 (the “Second Extension Note”), and on the same date, the Board delivered to the Sponsor a written request to draw down $60,000 for the first month of the Second Extension. On July 21, 2023, Continental Stock Transfer & Trust Company, the Company’s trustee, confirmed the receipt of the $60,000 Contribution.

 

On August 18, 2023, the Board determined to implement a second of the Second Extension to allow additional time for the Company to complete its initial business combination. In connection with this Extension and pursuant to the Second Extension Note, the Board delivered to the Sponsor a written request to draw down $60,000 for the second month of the Second Extension. On August 21, 2023, the Sponsor deposited $60,000 into the Company’s Trust Account in connection with this Extension.

 

On August 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from August 22, 2023 for an additional month to September 22, 2023, the second of three potential one-month Second Extensions of the Deadline Date available to the Company.

 

On September 15, 2023, the Board determined to implement a third of the Second Extension to allow additional time for the Company to complete its initial business combination. In connection with this Extension and pursuant to the Second Extension Note, the Board delivered to the Sponsor a written request to draw down $60,000 for the third month of the Second Extension. On September 21, 2023, the Sponsor deposited $60,000 into the Company’s Trust Account in connection with this Extension.

 

On September 21, 2023, the Company issued a press release announcing that its Board has elected to extend the Deadline Date from September 22, 2023 for an additional month to October 22, 2023, the last of three potential one-month Second Extensions of the Deadline Date available to the Company.

 

On September 29, 2023, the Company held a special meeting of its stockholders in connection with its proposed business combination. At the special meeting, the Company’s stockholders approved (1) the business combination agreement, dated as of July 28, 2022 (as amended by the amendments to the business combination agreement, dated as of September 29, 2022, June 29, 2023, July 18, 2023, August 25, 2023, September 8, 2023, and September 11, 2023, and as may be further amended or restated from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a European company incorporated in Germany (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”) and the transactions contemplated thereby (the “Business Combination”), pursuant to which, among other things, (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the U.S. Securities and Exchange Commission (“SEC”) guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions. A total of 884,880 shares of the Company’s Class A Common Stock were presented for redemption in connection with the special meeting, 100,000 shares of which subsequently revoked the redemption request, making the actual shares presented for redemption to be 784,880.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”) (see Note 9).

 

Risks and Uncertainties

 

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) as a pandemic which continues to spread throughout the United States and the world. As of the date the unaudited condensed financial statements were issued, there was considerable uncertainty around the expected duration of this pandemic. Management continues to evaluate the impact of the COVID-19 pandemic, and the Company has concluded that while it is reasonably possible that COVID-19 could have a negative effect on identifying a target company for a Business Combination, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

 

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the “IR Act”), which, among other things, generally imposes a 1% U.S. federal excise tax (the “Excise Tax”) on certain repurchases of stock by “covered corporations” (which include publicly traded domestic (i.e., U.S.) corporations) occurring on or after January 1, 2023. The Excise Tax is imposed on the repurchasing corporation itself, not its stockholders from which the stock is repurchased. Because the Company is a Delaware corporation and its securities are trading on the NYSE American, the Company is a “covered corporation” for this purpose. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury (the “Treasury”) has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the Excise Tax. On December 27, 2022, the Treasury issued a notice that provides interim operating rules for the Excise Tax, including rules governing the calculation and reporting of the Excise Tax, on which taxpayers may rely until the forthcoming proposed Treasury regulations addressing the Excise Tax are published. Although such notice clarifies certain aspects of the Excise Tax, the interpretation and operation of other aspects of the Excise Tax remain unclear, and such interim operating rules are subject to change.

 

Whether and to what extent the Company would be subject to the Excise Tax on a redemption of shares of Class A common stock or other stock issued by the Company would depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the Excise Tax, (ii) the fair market value of the redemption treated as a repurchase of stock in connection with the initial Business Combination, an extension or otherwise, (iii) the structure of the initial Business Combination, (iv) the nature and amount of any “PIPE” or other equity issuances (whether in connection with the initial Business Combination or otherwise) issued within the same taxable year of a redemption treated as a repurchase of stock and (v) the content of forthcoming regulations and other guidance from the Treasury. As noted above, the Excise Tax would be payable by the Company and not by the redeeming holder, and only limited guidance on the mechanics of any required reporting and payment of the Excise Tax on which taxpayers may rely have been issued to date. The imposition of the Excise Tax could cause a reduction in the cash available on hand to complete the initial Business Combination or for effecting redemptions and may affect the Company’s ability to complete the initial Business Combination, fund future operations or make distributions to stockholders. In addition, the Excise Tax could cause a reduction in the per share amount payable to the public stockholders in the event the Company liquidates the Trust Account due to a failure to complete the initial Business Combination within the requisite time frame.

 

On July 19, 2023, the Company’s stockholders elected to redeem 1,082,596 shares for a total payment of $11,635,781. In addition, On September 29, 2023, the Company’s stockholders elected to redeem 784,880 shares for a total payment of $8,668,990. The Company evaluated the classification and accounting of the share/ stock redemption under Accounting Standards Codification (“ASC”) 450, “Contingencies”. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset or the incurrence of a liability can range from probable to remote. A contingent liability must be reviewed at each reporting period to determine appropriate treatment. The Company evaluated the current status and probability of completing a Business Combination as of September 30, 2023 and concluded that it is probable that a contingent liability should be recorded. As of September 30, 2023, the Company recorded $203,048 of excise tax liability calculated as 1% of the shares redeemed.

 

Going Concern and Capital Resources

 

As of September 30, 2023, the Company had $26,400 in its operating bank accounts (inclusive of $17,864 restricted cash to pay for the Company’s franchise taxes), $10,673,205 in securities held in the Trust Account (inclusive of $8,668,990 restricted amount to pay for the redeeming stockholders) to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $7,831,850. As of September 30, 2023, approximately $313,029 of the amount on deposit in the Trust Account represented interest and dividend income, which is available to pay the Company’s redeeming stockholders and tax obligations.

 

On October 19, 2023, as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management believes that the liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern.

v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on March 30, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

 

Emerging Growth Company

 

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $8,536 and $13,612 of cash as of September 30, 2023 and December 31, 2022, respectively, and no cash equivalents.

 

Cash - Restricted

 

Cash that is encumbered or otherwise restricted as to its use is included in cash – restricted. As of September 30, 2023 and December 31, 2022, the balance was $17,864 and $0, respectively. Cash – restricted at September 30, 2023 represents cash that was withdrawn from the Trust Account to pay franchise taxes but is yet to be utilized.

 

Cash and Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s cash and investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s cash and investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

As of September 30, 2023 and December 31, 2022, the Company had $10,673,205 and $21,752,492 in cash and investments held in Trust Account, respectively. The balance of $10,673,205 as of September 30, 2023 includes a restricted amount of $8,668,990 which represents the amounts payable to the redeeming stockholders in connection with the special meeting held on September 29, 2023.

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Total offering costs amounted to $13,116,818, out of which $12,245,042 was charged against the carrying value of Class A common stock upon the completion of the IPO.

  

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

 

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s effective tax rate was (1.51)% and (57.46)% for the three months ended September 30, 2023 and 2022, respectively, and (6.47)% and (18.87)% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, primarily due to the extinguishment of the derivative liability and valuation allowance on the deferred tax assets.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

Derivative Liabilities

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has determined forward purchase agreements are derivative instruments.

 

Class A Common Stock Subject to Possible Redemption

 

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock sold in the IPO and over-allotment features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 181,460 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

 

Under ASC 480-10-S99, the Company has elected to recognize changes in redemption value immediately as they occur and adjust the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

Immediately upon the closing of the IPO and over-allotment, the Company recognized the accretion from the initial book value to redemption amount value. This method would view the end of the reporting period as if it were also the redemption date of the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

As of September 30, 2023 and December 31, 2022, the shares of Class A common stock subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:

 

Gross proceeds  $230,000,000 
Less:     
Fair value of Public Warrants at issuance   (15,310,355)
Class A shares issuance costs   (12,245,042)
Add:     
Accretion of carrying value to redemption value   32,155,397 
Class A common stock subject to possible redemption at December 31, 2021   234,600,000 
Less: Redemption of common stock subject to possible redemption   (216,004,846)
Plus: Accretion of carrying value to redemption value   2,465,885 
Class A common stock subject to possible redemption, December 31, 2022   21,061,039 
Less: Redemption of common stock subject to possible redemption   (20,304,771)
Add: Accretion of carrying value to redemption value   1,243,330 
Class A common stock subject to possible redemption, September 30, 2023 (unaudited)  $1,999,598 

 

Net Loss per Common Share

 

The Company has two classes of common shares, which are referred to as Class A common stock and Class B common stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares. On September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period presented. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per common share for each class of stock.

 

   For the Three Months Ended September 30, (unaudited) 
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(497,347)  $(1,786,232)  $(404,021)  $(135,178)
                     
Denominator:                    
Weighted average shares outstanding   2,241,388    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.22)  $(0.22)  $(0.02)  $(0.02)

 

   For the Nine Months Ended September 30, (unaudited)  
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(555,074)  $(1,586,448)  $(1,208,501)  $(404,340)
                     
Denominator:                    
Weighted average shares outstanding   2,816,576    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.20)  $(0.20)  $(0.05)  $(0.05)

 

Accounting for Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants (defined below) issued pursuant to the warrant agreements qualify for equity accounting treatment.

 

Recent Accounting Pronouncements

 

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

v3.23.3
Initial Public Offering and Over-Allotment
9 Months Ended
Sep. 30, 2023
Initial Public Offering and Over-Allotment [Abstract]  
INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

NOTE 3. INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

 

Pursuant to the IPO, and including the underwriters’ exercise of their over-allotment option, the Company sold 23,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock (such shares of Class A common stock included in the Units being offered, the “Public Shares”), and one-half a redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

v3.23.3
Private Placement
9 Months Ended
Sep. 30, 2023
Private Placement [Abstract]  
PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

 

On October 22, 2021, simultaneously with the consummation of the IPO and the underwriters’ exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 1,060,000 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $10,600,000. Each whole Private Placement Unit will consist of one share of Class A common stock and one-half of a redeemable warrant (“Private Placement Warrant”). Each whole Private Placement Warrant will be exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and all underlying securities will be worthless.

v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On June 4, 2021, the Sponsor was issued 5,900,000 shares of Class B common stock. Subsequently, on June 24, 2021, the Sponsor paid certain costs totaling $25,000 on behalf of the Company as consideration for 5,900,000 issued on June 4, 2021. On September 23, 2021, the Company effected a 1.36440678 for 1 stock split of its common stock so that the Sponsor owns an aggregate of 8,050,000 Founder Shares. The Sponsor paid approximately $0.003 per share for the Founder Shares. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 7. Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment, at any time. The Initial Stockholders had agreed to forfeit up to 1,050,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. Since the underwriters exercised the over-allotment option in full, the Sponsor did not forfeit any Founder Shares.

 

Subject to limited exceptions, each holder of Founder Shares has agreed that, during the period from July 28, 2022 through the earlier to occur of (the “Termination Date”) (a) the closing of the e.GO Transaction (as such term is defined in Note 6) (the “Closing”), (b) such date and time as the Business Combination Agreement (as such term is defined in Note 6) is validly terminated in accordance with its terms and (c) the mutual written agreement of the parties to that certain Sponsor Letter Agreement (as such term is defined in Note 6), except as contemplated by such Sponsor Letter Agreement and the Business Combination Agreement, it shall not, and shall cause its affiliates not to, without the prior written consent of e.GO and the Company (which consent may be given or withheld by e.GO and the Company in their sole discretion), (i) offer for sale, sell (including short sales), transfer, tender, pledge, convert, encumber, assign or otherwise dispose of, directly or indirectly (including by gift, merger, tendering into any tender offer or exchange offer or otherwise) (collectively, a “Transfer”), or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer of, any or all of its Founder Shares; (ii) grant any proxies or powers of attorney with respect to any or all of its Founder Shares held by it (except in connection with voting by proxy at a meeting of shareholders of the Company); or (iii) permit to exist any mortgage, pledge, security interest, encumbrance, lien, license or sub-license, charge or other similar encumbrance or interest (including, in the case of any equity securities, any voting, transfer or similar restrictions) (a “Lien”) with respect to any or all of its Founder Shares, other than those created by the Sponsor Letter Agreement; provided that any Lien with respect to the Founder Shares that would not prevent, impair or delay its ability to comply with the terms and conditions of the Sponsor Letter Agreement shall be permitted and will not be deemed to violate the restrictions contained above.

 

Additionally, subject to limited exceptions, each holder of Founder Shares has agreed that for a period from the Closing through the date that is 180 days thereafter, it shall not, and shall cause its affiliates not to, Transfer, or enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or consent to, a Transfer of, any or all of its TopCo Covered Shares. “TopCo Covered Shares” means (i) with respect to the Sponsor, 75% of the TopCo Ordinary Shares to be issued to the Sponsor pursuant to the Business Combination Agreement (it being understood that the terms of this paragraph shall not apply to the remaining 25% of such TopCo Ordinary Shares) and (ii) with respect to the Athena Insiders (as such term is defined in Note 6), all of the TopCo Ordinary Shares to be issued pursuant to the Business Combination Agreement.

 

Related Party Loans

 

On June 4, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of December 31, 2021, or the completion of the IPO. An amount of $117,994 was borrowed under the Note and repaid on October 22, 2021. There was no balance outstanding as of September 30, 2023 and December 31, 2022. This facility is no longer available.

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into Units of the post Business Combination entity at a price of $10.00 per Unit. The Units would be identical to the Private Placement Units. As of September 30, 2023, the promissory notes stated below were entered into which fall under the Working Capital Loans structure.

 

On January 17, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $676,149 (the “Extension Note”). On the same date, in connection with advances the Sponsor may make in the future to the Company for working capital expenses in connection with the Company’s initial business combination, the Company issued a separate unsecured promissory note to the Sponsor in the principal amount of up to $400,000 (the “Working Capital Note”, together with the Extension Note, the “Notes”). Both Notes bear no interest and are repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the Company’s liquidation. If the Company does not consummate an initial business combination by the Deadline Date, the Notes will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Notwithstanding the foregoing, under both Notes, following the closing of the Company’s initial business combination, the Sponsor may elect to convert all or any portion of the unpaid principal balance of the Note into units of the post-business combination entity at $10.00 per unit (the “Conversion Units”), with each unit being identical to the private placement units sold to the Sponsor in connection with the Company’s IPO. The Conversion Units and their underlying securities are entitled to the registration rights set forth in the Notes. On May 19, 2023, the Company and Sponsor entered into an amendment and restatement to the Working Capital Note in order to increase the aggregate principal amount of borrowings to an aggregate principal amount of up to $600,000. On July 7, 2023, the Company and Sponsor entered into an amendment and restatement to the Working Capital Note in order to increase the aggregate principal amount of borrowings to an aggregate principal amount of up to $900,000. As of September 30, 2023, the Sponsor funded $738,568, and there is $161,432 available under the Working Capital Note which has not yet funded. The $676,149 Extension Note was fully funded as of September 30, 2023. As of September 30, 2023 and December 31, 2022, the total outstanding balance of the Notes is $1,414,717 and $0, respectively.

 

In connection with the Sponsor’s Contribution for the Second Extension, on July 20, 2023, the Company issued an unsecured promissory note to the Sponsor with a principal amount equal to $180,000 (the “Second Extension Note”). The Second Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the Company’s liquidation. If the Company does not consummate an initial business combination by the Deadline Date, the Second Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. Notwithstanding the foregoing, under the Second Extension Note, following the closing of the Company’s initial business combination, the Sponsor may elect to convert all or any portion of the unpaid principal balance of the Second Extension Note into Conversion Units at $10.00 per unit, with each unit being identical to the private placement units sold to the Sponsor in connection with the Company’s IPO, provided that the aggregate amount the Sponsor may convert under the Second Extension Note, the Extension Note, and the Working Capital Note, as amended on May 19, 2023 and July 7, 2023, shall not exceed $1,500,000. The Conversion Units and their underlying securities are entitled to the registration rights set forth in the Second Extension Note.

 

In connection with funding the Extension Note, the Sponsor entered into an agreement with a member of the Sponsor. Pursuant to such agreement, the Sponsor agreed to assign and transfer to such member a ratio of 1 Founder Share for every $1.5 amount funded upon the closing of the Business Combination. As of September 30, 2023, such member of the Sponsor loaned $230,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

On May 19, 2023, the Sponsor entered into an agreement with a third party investor. Pursuant to such agreement, the Sponsor will transfer one share of Class A common stock of the Company for each dollar funded upon the closing of a Business Combination. As of September 30, 2023, such third party investor loaned $510,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

Due to Related Parties

 

The balance due to related parties mainly represents the amounts owed by the Company to an entity affiliated with the Sponsor for support services. As of September 30, 2023 and December 31, 2022, the Company has an outstanding due to related parties of $82,605 and $0, respectively.

 

Support Services

 

The Company intends to pay an entity affiliated with the Sponsor a fee of approximately $10,000 per month following the consummation of the IPO until the earlier of the consummation of the Business Combination or liquidation for office space and administrative support services. For the three and nine months ended September 30, 2023, $30,000 and $90,000, respectively, have been incurred and $10,000 has been paid under this agreement. For the three and nine months ended September 30, 2022, $30,000 and $90,000, respectively, have been incurred and paid under this agreement.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of Founder Shares, Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A common stock) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the final prospectus relating to the IPO to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On October 22, 2021, the underwriters elected to fully exercise the over-allotment option purchasing 3,000,000 Units.

 

The underwriters were paid a cash underwriting discount of $0.20 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $4,000,000 in the aggregate at the closing of the IPO. The underwriters have agreed to defer the cash underwriting discount of $0.20 per share related to the over-allotment to be paid upon completion of a Business Combination ($600,000 in the aggregate). In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $8,050,000 from the closing of the IPO. The total deferred fee is $8,650,000, consisting of the $8,050,000 deferred portion and the $600,000 cash discount agreed to be deferred until completion of a Business Combination. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.

 

On December 8, 2022, Citi, as representative of the underwriters, agreed to formally waive the deferred underwriting commissions of $8,650,000 in full, pursuant to a deferred fee waiver letter agreement between Citi and the Company only upon the successful Business Combination under the e.GO transaction as described below.

 

Business Combination Agreement

 

On July 28, 2022, the Company entered into a Business Combination Agreement (as amended by that certain first amendment to the Business Combination Agreement on September 29, 2022, and as it may be further amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a German company (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of TopCo (“Merger Sub”), for the Company’s initial Business Combination (the “e.GO Transaction”). Pursuant to the Business Combination Agreement, among other things, (i) TopCo will issue to the e.GO’s equity securities (the “e.GO Shareholders”) and convertible loan lenders of e.GO (the “Lenders”) an aggregate of up to 79,019,608 TopCo Ordinary Shares, representing aggregate consideration to the e.GO Shareholders of $800,000,000, 30,000,000 of such shares will be unvested and subject to an earn-out (the “Earn-Out Shares”), in exchange for the contribution by the e.GO Shareholders of all of the paid up no-par value shares of e.GO to TopCo and the convertible loans held by the Lenders, assuming that all e.GO Shareholders and Lender participate in the exchange; (ii) each issued and outstanding share of the Company’s Class A common stock will be automatically cancelled and extinguished and converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”), (iii) each issued and outstanding share of the Company’s Class B common stock will be automatically cancelled and extinguished and converted into a number of shares of Surviving Company Common Stock calculated as the sum of (x) one plus (y) the lower of (a) the total amount funded under the credit agreement, dated September 29, 2022, between e.GO, Brucke Funding LLC, Brucke Agent LLC and certain lenders party thereto (the “Bridge Financing”), divided by $15,000,000 and multiplied with one-fifth and (b) one-fifth; (iv) TopCo will change its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (v) Merger Sub will merge with and into the Company, with the Company being the Surviving Company and, after giving effect to the merger, becoming a direct, wholly owned subsidiary of TopCo; (vi) each share of the Company’s common stock will be converted into one share of the Surviving Company Common Stock; (vii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one TopCo Ordinary Share; and (viii) each outstanding warrant to purchase a share of the Company’s Class A common stock will be converted into a warrant to purchase a TopCo Ordinary Share on the same contractual terms and conditions as were in effect with respect to each warrant prior to the e.GO Transaction; and (ix) TopCo, the Company, the Sponsor, certain of the Company’s officers and directors, certain members of the Sponsor and/or their respective affiliates will enter into an amended and restated registration rights agreement pursuant to which TopCo will agree to register for resale, pursuant to Rule 415 of the Securities Act, certain TopCo Ordinary Shares and other equity securities of TopCo that are held by the parties thereto from time to time and the parties thereto will be provided customary demand and piggyback registration rights.

 

On June 29, 2023, the Company entered into a second amendment to the Business Combination Agreement (the “Second Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which, among other things, the following terms of the Business Combination Agreement were amended: (a) Treatment of Athena Class B Common Stock – In connection with the closing of the Business Combination and subject to the approval of the Company’s stockholders, each issued and outstanding share of the Company’s Class B common stock will be converted into 1.05 TopCo ordinary shares, or a conversion of 8,050,000 shares into 8,452,500 shares. The 1:1.05 conversion ratio is a clarification and finalization of the conversion ratio of such shares originally contemplated by the First Amendment to the Business Combination Agreement, which was based on the amount that may have been funded under the Bridge Financing. Final disbursement amounts under the Bridge Financing totaled $3,750,000 out of a maximum of $15,000,000, resulting in a 1:1.05 conversion ratio under the First Amendment to the Business Combination Agreement out of a maximum 1:1.2 conversion ratio; (b) Requisite Lock-up Percentage of e.GO Shareholders and Convertible Note Lenders – The Business Combination Agreement previously required all of e.GO’s shareholders and convertible loan lenders to enter into lock-up agreements pursuant to which they agreed not to effect any sale or distribution of any equity securities of TopCo issued to them at the closing of the Business Combination until the date that is six months after the closing. Pursuant to the Second Amendment to the Business Combination Agreement, such requirement was reduced to restrict the sale or distribution of 75% of the pro forma share capital of e.GO on a fully diluted basis as of the date of the Second Amendment to the Business Combination Agreement; and (c) Outside Date Termination Event – The outside date to terminate the Business Combination Agreement was extended from September 30, 2023 to September 30, 2023.

 

On July 18, 2023, the Company entered into a third amendment to the Business Combination Agreement (the “Third Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which the treatment of the Company’s Class B common stock was amended that, in connection with the closing of the Business Combination, each issued and outstanding share of the Company’s Class B common stock will be converted into TopCo ordinary shares on a one-for-one basis, instead of 1:1.05, as had been the case under the Second Amendment to the Business Combination Agreement. The one-for-one conversion ratio aligns with what is currently in the Company’s Charter.

 

On August 25, 2023, the Company entered into a fourth amendment to the Business Combination Agreement (the “Fourth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which, among other things, certain terms of the Business Combination Agreement (including with respect to the transaction steps, joint covenants of the parties, and the conditions to the obligations of the parties) were amended to reflect:

 

Warrant Exchange. The Business Combination Agreement previously provided that each outstanding warrant to purchase a share of the Company’s Class A common stock, par value $0.0001 per share, of the Company’s (the “Athena Class A Common Stock” and such warrants, the “Athena Warrants”) will be converted into a warrant to purchase a newly issued ordinary share, nominal value €0.12 per share, of TopCo (the “TopCo Share”) on the same contractual terms and conditions as were in effect with respect to each warrant prior to the Business Combination at the closing of the Business Combination (the “Closing”). Pursuant to the Fourth Amendment to the Business Combination Agreement, immediately prior to the Closing, each outstanding Athena Warrant will instead, subject to the approval of warrant holders of the Company, be cancelled and exchanged for 0.175 shares of Class A Common Stock, which will subsequently, in connection with the Closing, be exchanged for newly issued TopCo Shares (the “Warrant Exchange”).

 

Revised Form of Earn-out Agreement. In connection with the proposed Warrant Exchange, the Company and e.GO renegotiated certain terms of the earn-out agreement, which TopCo, the Company and holders of e.GO’s equity securities (the “e.GO Shareholders”) have agreed to enter into prior to the Closing, pursuant to which, among other things, TopCo will issue or cause to be issued to the e.GO Shareholders 30,000,000 Earn-Out Shares at the Closing. 20,000,000 of the Earn-Out Shares will be divided into four equal 5,000,000 share tranches, with each tranche subject to immediate vesting and release of trading and voting restrictions if the trading price per TopCo Share at any point during the trading hours of a trading day is greater than or equal to $12.50, $15.00, $20.00 and $25.00, respectively, for any 20 trading days within any period of 30 consecutive trading days during the five-year period following the Closing. The remaining 10,000,000 of such Earn-Out shares will vest immediately as of the Closing and will be subject to a 12-month lock-up.

 

On September 8, 2023, the Company entered into a fifth amendment to the Business Combination Agreement (the “Fifth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which certain terms of the Business Combination Agreement were amended to clarify the mechanics of the warrant exchange that is to occur at the closing of the Business Combination (the “Closing”), subject to the approval of Athena’s warrant holders.

 

Further, on September 11, 2023, the Company entered into a sixth amendment to the Business Combination Agreement (the “Sixth Amendment to the Business Combination Agreement”), by and between the Company and e.GO, pursuant to which certain terms of the Business Combination Agreement were amended to reflect the potential for TopCo Shares to be listed on Nasdaq following the Closing.

 

On September 29, 2023, the Company held a special meeting of its stockholders in connection with its proposed business combination. At the special meeting, the Company’s stockholders approved (1) the business combination agreement, dated as of July 28, 2022 (as amended by the amendments to the business combination agreement, dated as of September 29, 2022, June 29, 2023, July 18, 2023, August 25, 2023, September 8, 2023, and September 11, 2023, and as may be further amended or restated from time to time, the “Business Combination Agreement”), by and among the Company, Next.e.GO Mobile SE, a European company incorporated in Germany (“e.GO”), Next.e.GO B.V., a Dutch private limited liability company and a wholly-owned subsidiary of e.GO (“TopCo”), and Time is Now Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of TopCo (“Merger Sub”) and the transactions contemplated thereby (the “Business Combination”), pursuant to which, among other things, (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the SEC guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”) (see Note 9).

 

Sponsor Letter Agreement

 

On July 28, 2022, the Company, the Sponsor, e.GO, TopCo and certain of the Company’s officers and directors (the “Athena Insiders”) entered into a Sponsor Letter Agreement, which was amended on September 29, 2022 (as it may be further amended, supplemented or otherwise modified from time to time, the “Sponsor Letter Agreement”), pursuant to which, among other things, the Sponsor and the Athena Insiders have agreed to (i) vote all of its, his or her shares of the Company’s Class A common stock to approve and adopt the Business Combination Agreement and the e.GO Transaction, (ii) waive its, his or her redemption rights with respect to its, his or her shares of the Company’s Class A common stock in connection with the e.GO Transaction, (iii) not transfer any of its, his or her shares of the Company’s Class A common stock until the Closing or termination of the Business Combination Agreement (except in limited circumstances), (iv) not transfer (a) with respect to the Sponsor, 75% of its TopCo shares and (b) with respect to all other Athena Insiders any of its, his or her TopCo ordinary shares until the date that is 180 days after the Closing (except in limited circumstances), (v) waive any adjustment to the conversion ratio set forth in the Company’s amended and restated certificate of incorporation or any other anti-dilution or similar protection with respect to the shares of the Company’s Class B common stock held by the Sponsor or the Athena Insiders, in each case, subject to the terms and conditions contemplated by the Sponsor Letter Agreement.

 

Pursuant to the Sponsor Letter Agreement, TopCo will indemnify the Sponsor from and against certain liabilities relating to the e.GO Transaction for a period of six years after the Closing and subject to an aggregate maximum indemnity of $4,000,000.

 

Forward Purchase Agreement

 

On September 29, 2022, the Company, TopCo, e.GO and Vellar Opportunity Fund SPV LLC – Series 3 (“Vellar”) entered into a Forward Purchase Agreement (the “Forward Purchase Agreement”) for an OTC equity prepaid share forward transaction (the “Forward Purchase Transaction”). Vellar agreed to waive any redemption rights with respect to any shares of the Company and shares of TopCo following the Closing of the e.GO Transaction (collectively, the “Shares”) in connection with the e.GO Transaction.

 

Pursuant to the terms of the Forward Purchase Agreement, Vellar intended, but was not obligated, to purchase through a broker in the open market from Public Stockholders who redeemed or indicated an intention to redeem, or from the Company, up to an aggregate amount of 15,000,000 shares of Class A common stock (the “Forward Purchase Shares”). Vellar could not beneficially own greater than 9.9% of the Shares on a post-combination pro forma basis. Upon Closing, or upon the date any assets from the Company’s Trust Account would be disbursed in connection with the e.GO Transaction, Vellar would be paid directly, out of the funds held in the Trust Account, an amount equal to (a) (i) the redemption price of shares of the Company’s Class A common stock redeemed by the Public Stockholders and purchased by Vellar, minus (ii) 10% of such amount and (b) the product of 1,500,000 multiplied by the redemption price of shares of the Company’s Class A common stock indicated to the Public Stockholders prior to the redemption deadline (as consideration for having purchased Class A common stock prior to Closing). From time to time following the Closing, Vellar, in its discretion, could sell the Forward Purchase Shares (such shares sold, the “Vellar Terminated Shares”) without payment obligation to TopCo until such time as the proceeds from the sales equal (i) 10% of the product of the number of the Forward Purchase Shares and the redemption price per share indicated to investors ahead of the Company’s redemption notice deadline or (ii) in the case of an event of default under the Bridge Financing, all amounts that are due to Vellar under such financing.

 

Upon the second anniversary of the Closing, TopCo would be obligated to pay to Vellar an amount equal to the product of (a) (x) 15,000,000 less (y) the number of Vellar Terminated Shares multiplied by (b) $2.50. Vellar could freely transfer or assign its rights under the Forward Purchase Agreement if the number of the Forward Purchase Shares it acquired would exceed 9.9% on a post-e.GO Transaction basis.

 

On March 3, 2023, the Forward Purchase Agreement was terminated.

 

Subscription Agreement

 

In connection with funding the Extension Note, the Sponsor entered into an agreement with a member of the Sponsor. Pursuant to such agreement, the Sponsor agreed to assign and transfer to such member a ratio of 1 Founder Share for every $1.5 amount funded upon the closing of the Business Combination. As of September 30, 2023, such member of the Sponsor loaned $230,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

 

On May 19, 2023, the Sponsor entered into an agreement with a third-party investor. Pursuant to such agreement, the Sponsor will transfer one share of Class A common stock of the Company for each dollar funded upon the closing of a Business Combination. As of September 30, 2023, such third-party investor loaned $510,000 to the Sponsor, which amount is included in the balance due to the Sponsor under the Extension Note described above.

v3.23.3
Stockholders’ Deficit
9 Months Ended
Sep. 30, 2023
Stockholders’ Deficit [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Class A Common Stock — The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 1,060,000 shares of Class A common stock issued and outstanding (excluding 181,460 and 2,048,936 shares subject to possible redemption, respectively).

 

Pursuant to the e.GO Transaction, if approved by the Company’s stockholders, at Closing, each issued and outstanding share of the Company’s Class A common stock will be automatically cancelled and extinguished and converted into one share the Surviving Company Common Stock.

 

Class B Common Stock — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 8,050,000 shares of Class B common stock outstanding.

 

Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

 

The Company’s Charter provides that the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, approximately 26.0% of the sum of the total number of all shares of common stock outstanding upon the completion of the IPO plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

 

Pursuant to the e.GO Transaction, if approved by the Company’s stockholders, at Closing, each issued and outstanding shares of Class B common stock will be automatically cancelled and extinguished and converted into a number of shares of Surviving Company Common Stock calculated as the sum of (x) one plus (y) the lower of (a) the total amount funded under the Bridge Financing divided by $15,000,000 and multiplied with one-fifth and (b) one-fifth, and, immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be exchanged for one TopCo Ordinary Share.

 

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. For the periods presented, there were no shares of preferred stock issued or outstanding.

 

Warrants — As of September 30, 2023 and December 31, 2022, the Company has 11,500,000 Public Warrants and 530,000 Private Placement Warrants outstanding (together, the “Warrants”). Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

 

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of the warrant agreements. No Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the offer and sale of the shares of common stock issuable upon exercise of the Warrants is not effective within a specified period following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their Warrants on a cashless basis.

 

Once the Warrants become exercisable, the Company may redeem the Warrants:

 

  in whole and not in part;
     
  at a price of $0.01 per Warrant;
     
  upon not less than 30 days’ prior written notice of redemption, to each Warrant holder; and
     
  if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the Warrant holders.

 

If and when the Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares upon exercise of the Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

If the Company calls the Warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the Public Warrant agreement and Private Warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the Warrants will not be adjusted for issuances of shares of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless.

 

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price.

 

The Private Placement Warrants are Identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Placement Warrants and the shares of common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable at the election of the holder on a “cashless basis”.

 

Neither the Placement Warrants nor the Public Warrants contain any provision that change dependent upon the characteristics of the holder of the Warrant.

v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.

 

At September 30, 2023 and December 31, 2022, the assets held in the Trust Account were held in treasury funds. All of the Company’s cash and investments held in the Trust Account are classified as trading securities.

 

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

       Quoted 
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
September 30, 2023 (unaudited)  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Cash and Investments held in Trust Account   1   $10,673,205   $          —   $        — 

 

       Quoted
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
December 31, 2022  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Investments held in Trust Account   1   $21,752,492   $            —   $    — 
                     
Liabilities:                    
Derivative liability – Forward Purchase Agreement   3   $   $   $1,730,000 

 

The Company utilizes a Put Model Option to value its forward purchase agreement at each reporting period, with changes in fair value recognized in the statements of operations. The estimated fair value of the forward purchase agreement liabilities is determined using Level 3 inputs. Inherent in put options pricing model are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the forward purchase agreement. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the forward purchase agreement. The expected life of the forward purchase agreement is assumed to be equivalent to their remaining contractual term. The forward purchase agreement was terminated on March 9, 2023.

 

For the three and nine months ended September 30, 2023 and 2022, there were no transfers between Levels 1, 2 or 3.

 

The following table provides quantitative information regarding Level 3 fair value measurements:

 

   December 31,
2022
 
Risk-free interest rate   4.40%
Term   2.25 
Expected volatility   78.20%
Exercise price  $2.50 
Stock price  $10.38 
Probability of transaction   50%

 

The following table presents the changes in the fair value of Forward Purchase Agreement:

 

   Forward 
   Purchase 
   Agreement 
Fair value as of September 29, 2022 (unaudited)  $1,430,000 
Change in valuation inputs or other assumptions   300,000 
Fair value as of December 31, 2022   1,730,000 
Gain on termination of derivative liability – Forward Purchase Agreement   (1,730,000)
Fair value as of September 30, 2023 (unaudited)  $ 
v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheets date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than stated below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On October 19, 2023 (the “Closing Date”), as contemplated by the Business Combination Agreement, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of TopCo. Additionally, on the Closing Date, (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”).

 

On the Closing Date, after giving effect to the redemption of an aggregate of 784,880 shares of Athena Class A Common Stock in accordance with the terms of Athena’s Amended and Restated Certificate of Incorporation, as amended (“SPAC Redemptions”), the e.GO Shareholders receiving shares pursuant to the Business Combination Agreement own approximately 85% of the outstanding TopCo Shares, including the 20,000,000 unvested Earn-Out Shares which are approximately 21% of the outstanding TopCo Shares.

 

On November 2, 2023, the Company paid the 784,880 redeeming Class A stockholders an amount of approximately $8.67 million.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on March 30, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

Emerging Growth Company

Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $8,536 and $13,612 of cash as of September 30, 2023 and December 31, 2022, respectively, and no cash equivalents.

Cash - Restricted

Cash - Restricted

Cash that is encumbered or otherwise restricted as to its use is included in cash – restricted. As of September 30, 2023 and December 31, 2022, the balance was $17,864 and $0, respectively. Cash – restricted at September 30, 2023 represents cash that was withdrawn from the Trust Account to pay franchise taxes but is yet to be utilized.

Cash and Investments Held in Trust Account

Cash and Investments Held in Trust Account

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s cash and investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s cash and investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

As of September 30, 2023 and December 31, 2022, the Company had $10,673,205 and $21,752,492 in cash and investments held in Trust Account, respectively. The balance of $10,673,205 as of September 30, 2023 includes a restricted amount of $8,668,990 which represents the amounts payable to the redeeming stockholders in connection with the special meeting held on September 29, 2023.

Offering Costs Associated with the Initial Public Offering

Offering Costs Associated with the Initial Public Offering

Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Total offering costs amounted to $13,116,818, out of which $12,245,042 was charged against the carrying value of Class A common stock upon the completion of the IPO.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

 

Income Taxes

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s effective tax rate was (1.51)% and (57.46)% for the three months ended September 30, 2023 and 2022, respectively, and (6.47)% and (18.87)% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, primarily due to the extinguishment of the derivative liability and valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

Derivative Liabilities

Derivative Liabilities

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company has determined forward purchase agreements are derivative instruments.

Class A Common Stock Subject to Possible Redemption

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock sold in the IPO and over-allotment features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 181,460 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

Under ASC 480-10-S99, the Company has elected to recognize changes in redemption value immediately as they occur and adjust the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

Immediately upon the closing of the IPO and over-allotment, the Company recognized the accretion from the initial book value to redemption amount value. This method would view the end of the reporting period as if it were also the redemption date of the security. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

 

As of September 30, 2023 and December 31, 2022, the shares of Class A common stock subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:

Gross proceeds  $230,000,000 
Less:     
Fair value of Public Warrants at issuance   (15,310,355)
Class A shares issuance costs   (12,245,042)
Add:     
Accretion of carrying value to redemption value   32,155,397 
Class A common stock subject to possible redemption at December 31, 2021   234,600,000 
Less: Redemption of common stock subject to possible redemption   (216,004,846)
Plus: Accretion of carrying value to redemption value   2,465,885 
Class A common stock subject to possible redemption, December 31, 2022   21,061,039 
Less: Redemption of common stock subject to possible redemption   (20,304,771)
Add: Accretion of carrying value to redemption value   1,243,330 
Class A common stock subject to possible redemption, September 30, 2023 (unaudited)  $1,999,598 
Net Loss per Common Share

Net Loss per Common Share

The Company has two classes of common shares, which are referred to as Class A common stock and Class B common stock (the “Founder Shares”). Earnings and losses are shared pro rata between the two classes of shares. On September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period presented. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per common share for each class of stock.

   For the Three Months Ended September 30, (unaudited) 
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(497,347)  $(1,786,232)  $(404,021)  $(135,178)
                     
Denominator:                    
Weighted average shares outstanding   2,241,388    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.22)  $(0.22)  $(0.02)  $(0.02)
   For the Nine Months Ended September 30, (unaudited)  
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(555,074)  $(1,586,448)  $(1,208,501)  $(404,340)
                     
Denominator:                    
Weighted average shares outstanding   2,816,576    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.20)  $(0.20)  $(0.05)  $(0.05)
Accounting for Warrants

Accounting for Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants (defined below) issued pursuant to the warrant agreements qualify for equity accounting treatment.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Class A Common Stock Reflected on the Balance Sheet As of September 30, 2023 and December 31, 2022, the shares of Class A common stock subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:
Gross proceeds  $230,000,000 
Less:     
Fair value of Public Warrants at issuance   (15,310,355)
Class A shares issuance costs   (12,245,042)
Add:     
Accretion of carrying value to redemption value   32,155,397 
Class A common stock subject to possible redemption at December 31, 2021   234,600,000 
Less: Redemption of common stock subject to possible redemption   (216,004,846)
Plus: Accretion of carrying value to redemption value   2,465,885 
Class A common stock subject to possible redemption, December 31, 2022   21,061,039 
Less: Redemption of common stock subject to possible redemption   (20,304,771)
Add: Accretion of carrying value to redemption value   1,243,330 
Class A common stock subject to possible redemption, September 30, 2023 (unaudited)  $1,999,598 
Schedule of Basic and Diluted Net Loss Per Share
   For the Three Months Ended September 30, (unaudited) 
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(497,347)  $(1,786,232)  $(404,021)  $(135,178)
                     
Denominator:                    
Weighted average shares outstanding   2,241,388    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.22)  $(0.22)  $(0.02)  $(0.02)
   For the Nine Months Ended September 30, (unaudited)  
   2023   2022 
   Class A
common stock
   Class B
common stock
   Class A
common stock
   Class B
common stock
 
Basic and diluted net loss per common share:                
Numerator:                
Allocation of net loss  $(555,074)  $(1,586,448)  $(1,208,501)  $(404,340)
                     
Denominator:                    
Weighted average shares outstanding   2,816,576    8,050,000    24,060,000    8,050,000 
Basic and diluted net loss per common share
  $(0.20)  $(0.20)  $(0.05)  $(0.05)
v3.23.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Schedule of Company’s Assets and Liabilities that are Measured at Fair Value The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
       Quoted 
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
September 30, 2023 (unaudited)  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Cash and Investments held in Trust Account   1   $10,673,205   $          —   $        — 
       Quoted
Prices in
   Significant 
Other
   Significant 
Other
 
       Active 
Markets
   Observable 
Inputs
   Unobservable
Inputs
 
December 31, 2022  Level   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Investments held in Trust Account   1   $21,752,492   $            —   $    — 
                     
Liabilities:                    
Derivative liability – Forward Purchase Agreement   3   $   $   $1,730,000 
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements The following table provides quantitative information regarding Level 3 fair value measurements:
   December 31,
2022
 
Risk-free interest rate   4.40%
Term   2.25 
Expected volatility   78.20%
Exercise price  $2.50 
Stock price  $10.38 
Probability of transaction   50%
Schedule of Changes in the Fair Value of Forward Purchase Agreement The following table presents the changes in the fair value of Forward Purchase Agreement:
   Forward 
   Purchase 
   Agreement 
Fair value as of September 29, 2022 (unaudited)  $1,430,000 
Change in valuation inputs or other assumptions   300,000 
Fair value as of December 31, 2022   1,730,000 
Gain on termination of derivative liability – Forward Purchase Agreement   (1,730,000)
Fair value as of September 30, 2023 (unaudited)  $ 
v3.23.3
Description of Organization and Business Operations (Details) - USD ($)
1 Months Ended 9 Months Ended
Oct. 22, 2021
Sep. 15, 2023
Aug. 18, 2023
Aug. 16, 2023
Jul. 21, 2023
Jul. 20, 2023
Jun. 20, 2023
Jun. 19, 2023
May 19, 2023
Apr. 18, 2023
Mar. 20, 2023
Feb. 17, 2023
Jan. 30, 2023
Jan. 17, 2023
Aug. 16, 2022
Oct. 22, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 29, 2023
Sep. 21, 2023
Jul. 28, 2023
Jun. 30, 2023
Jun. 21, 2023
May 22, 2023
Apr. 20, 2023
Mar. 21, 2023
Jan. 23, 2023
Dec. 31, 2022
Description of Organization and Business Operations (Details) [Line Items]                                                        
Gross proceeds                                 $ (11,635,781)                    
Offering costs                                 13,116,818                      
Underwriting fees                                 4,000,000                      
Deferred underwriting fees                                 8,650,000                      
Other offering costs                                 $ 466,818                      
Contribution, description                                 the Company issued a press release announcing that, in connection with a special meeting of stockholders (the “Extension Meeting”) to be held for the purpose of considering and voting on, among other proposals, a proposal to amend the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) to provide the Company with the right to extend the date (the “Deadline Date”) by which it must consummate an initial business combination (the “Extension”) up to six times for an additional one month each time, from January 22, 2023 to up to July 22, 2023, if the Extension Amendment is approved at the Extension Meeting and an Extension is implemented, the Sponsor, or its designees will deposit into the Trust Account as a loan (a “Contribution”, and the Sponsor or its designee making such Contribution, a “Contributor”), the lesser of (x) $121,000 or (y) $0.055 per public share multiplied by the number of public shares outstanding, on each of the following dates: (i) January 23, 2023; and (ii) one business day following the public announcement by the Company disclosing that the Company’s board of directors (the “Board”) has determined to extend the Deadline Date for an additional month in accordance with the Extension (each date on which a Contribution is to be deposited into the Trust Account, a “Contribution Date”).                      
Sponsor amount     $ 60,000       $ 112,691   $ 112,691 $ 112,691 $ 112,691 $ 112,691   $ 112,691                            
Sponsor deposited amount                       $ 112,691                     $ 112,691 $ 112,691 $ 112,691 $ 112,691 $ 112,691  
Aggregate global market price (in Dollars per share)                         $ 802.01                              
Least cost                         $ 40,000,000                              
Redemption limitation amendment, description                                 (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate a business combination unless the Company has net tangible assets of at least $5,000,001 (the “Redemption Limitation Amendment Proposal”). The Sponsor, has agreed that if the Second Extension Amendment is implemented, the Sponsor or its designees will deposit into the Trust Account as a loan of $60,000 (the “Second Contribution”) on each of the following dates: (i) July 20, 2023; and (ii) one business day following the public announcement by the Company disclosing that its board of directors has determined to extend the Deadline Date for an additional month in accordance with the Second Extension Amendment.                      
Redemption shares (in Shares)                                           1,082,596            
Security held in trust account                                 $ 8,668,990       $ 10.48            
Unsecured promissory note           $ 180,000                                            
Contribution cost         $ 60,000                                              
Sponsor deposit     $ 60,000                                 $ 60,000                
Sponsor withdrawn   $ 60,000                                                    
Share redemption (in Shares)                                 784,880                      
Business combination agreement, description                                 (i) TopCo issued to the holders of e.GO’s equity securities, including certain former convertible loan lenders of e.GO (the “e.GO Shareholders”), an aggregate of up to 79,019,608 newly issued ordinary shares, nominal value €0.12 per share, of TopCo (the “TopCo Shares”) inclusive of 30,000,000 shares, 20,000,000 of which will be unvested and subject to an earn-out over a certain period, while 10,000,000 shares will vest immediately as of the Closing Date and will be subject to a 12-month lock-up, in each case as described below (the “Earn-Out Shares”); (ii) TopCo changed its legal form from a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) to a Dutch public limited liability company (naamloze vennootschap); (iii) the Merger effectuated, with the Company as the surviving company in the Merger (the “Surviving Company”) and in connection with the Merger, each share of Class A common stock par value $0.0001 of the Company (the “Athena Class A Common Stock”) and each issued and outstanding share of Class B common stock, par value $0.0001 per share, of the Company (the “Athena Class B Common Stock”) was converted into one share of common stock, par value $0.0001 per share, of the Surviving Company (the “Surviving Company Common Stock”); (iv) each of the resulting shares of Surviving Company Common Stock was automatically exchanged for one TopCo Share; and (v) each outstanding warrant to purchase a share of the Company Class A Common Stock (the “Athena Warrants”) was automatically cancelled and exchanged for 0.175 TopCo Shares per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”) ((i) through (v) together, the “Business Combination”) (see Note 9)                      
U.S. federal excise tax percentage                             1.00%                          
Share redeemed (in Shares)               1,082,596                                        
Operating Lease, Payments               $ 11,635,781                                        
Redeemable shares (in Shares)               784,880                                        
Total Payment               $ 8,668,990                                        
Excise and Sales Taxes               $ 203,048                                        
Shares Acquired, Weighted Average Discount to Net Assets, Percentage               1.00%                 9.90%                      
Operating bank accounts               $ 26,400                                        
Restricted cash                                 $ 17,864                    
Capital Resources [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Security held in trust account                                 10,673,205                      
Restricted cash                                 8,668,990                      
Working capital deficit                                 7,831,850                      
Deposit amount                                 $ 313,029                      
Fair Market [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Excise tax percentage       1.00%                                                
IPO [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Overallotment option (in Shares) 23,000,000                                                      
Shares issued price per share (in Dollars per share) $ 10                             $ 10                        
Gross proceeds                               $ 230,000,000                        
Sale of stock price (in Dollars per share)                                 $ 10.2                      
Net proceeds                                 $ 234,600,000                      
Private Placement [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Sale of stock units (in Shares)                                 1,060,000                      
Sale of stock price (in Dollars per share)                                 $ 10                      
Generating gross proceeds                                 $ 10,600,000                      
Sponsor [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Sponsor amount           $ 60,000                                            
Franchise [Member] | Capital Resources [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Restricted cash                                 $ 17,864                      
Common Class A [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Common share (in Shares)                                 1,060,000   884,880                 1,060,000
Number of units issued (in Shares)                                     100,000                  
Business Combination [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Deferred underwriting fees                                 $ 8,650,000                      
Series of Individually Immaterial Business Acquisitions [Member]                                                        
Description of Organization and Business Operations (Details) [Line Items]                                                        
Merger acquisition, description                                 (i) Merger Sub will merge with and into the Company, with the Company surviving and continuing as a direct, wholly-owned subsidiary of TopCo (the “Merger”), (ii) after giving effect to the Merger, each issued and outstanding share of the Company’s Common Stock will be converted into a number of shares of common stock, par value $0.0001 per share, of the company surviving the Merger (the “Surviving Company Common Stock”), (iii) immediately thereafter, each of the resulting shares of Surviving Company Common Stock will be automatically exchanged for one ordinary share, nominal value of €0.12 per share, of TopCo (the “TopCo Share”), and (iv) in connection therewith and subject to the approval of the public warrant holders of the Company at the Warrant Holders Meeting, each outstanding warrant to purchase a share of the Company’s Class A Common Stock (the “Athena Warrants”) will be automatically cancelled and exchanged for 0.175 TopCo Shares (the “Warrant Shares”) per Athena Warrant, with any fractional entitlement being rounded down (the “Warrant Exchange”), and (2) to approve and adopt, on a non-binding advisory basis, certain governance provisions in the proposed TopCo Articles of Association, which are being presented separately in accordance with the U.S. Securities and Exchange Commission (“SEC”) guidance to give stockholders the opportunity to present their separate views on important corporate governance provisions                      
v3.23.3
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Summary of Significant Accounting Policies (Details) [Line Items]          
Cash $ 8,536   $ 8,536   $ 13,612
Restricted cash 17,864   17,864   0
Cash and investments held in trust account 10,673,205   10,673,205   $ 21,752,492
Restricted amount 8,668,990   8,668,990    
Offering costs $ 13,116,818   13,116,818    
Federal depository insurance corporation coverage limit     $ 250,000    
Percentage of effective tax rate (1.51%) (57.46%) (6.47%) (18.87%)  
Percentage of statutory tax rate 21.00% 21.00% 21.00% 21.00%  
Common stock subject to possible redemption (in Shares)     181,460   181,460
Class A Common Stock [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Offering costs $ 12,245,042   $ 12,245,042    
Investments Held in Trust Account [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Restricted amount $ 10,673,205   $ 10,673,205    
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Class A Common Stock Reflected on the Balance Sheet - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Class A Common Stock Reflected on the Balance Sheet [Abstract]      
Gross proceeds     $ 230,000,000
Less:      
Fair value of Public Warrants at issuance     (15,310,355)
Class A shares issuance costs     (12,245,042)
Add:      
Add: Accretion of carrying value to redemption value $ 1,243,330 $ 2,465,885 32,155,397
Class A common stock subject to possible redemption 1,999,598 21,061,039 $ 234,600,000
Less: Redemption of common stock subject to possible redemption $ (20,304,771) $ (216,004,846)  
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Common Stock [Member]        
Numerator:        
Allocation of net loss $ (497,347) $ (404,021) $ (555,074) $ (1,208,501)
Denominator:        
Weighted average shares outstanding 2,241,388 24,060,000 2,816,576 24,060,000
Basic net loss per share $ (0.22) $ (0.02) $ (0.2) $ (0.05)
Class B Common Stock [Member]        
Numerator:        
Allocation of net loss $ (1,786,232) $ (135,178) $ (1,586,448) $ (404,340)
Denominator:        
Weighted average shares outstanding 8,050,000 8,050,000 8,050,000 8,050,000
Basic net loss per share $ (0.22) $ (0.02) $ (0.2) $ (0.05)
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Common Stock [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share (Parentheticals) [Line Items]        
Diluted net loss per share $ (0.22) $ (0.02) $ (0.20) $ (0.05)
Class B Common Stock [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share (Parentheticals) [Line Items]        
Diluted net loss per share $ (0.22) $ (0.02) $ (0.20) $ (0.05)
v3.23.3
Initial Public Offering and Over-Allotment (Details)
Sep. 30, 2023
$ / shares
shares
Over-Allotment Option [Member]  
Initial Public Offering and Over-Allotment (Details) [Line Items]  
Exercise over-allotment option (in Shares) | shares 23,000,000
Price per share unit $ 10
Class A Common Stock [Member]  
Initial Public Offering and Over-Allotment (Details) [Line Items]  
Price per share $ 11.5
v3.23.3
Private Placement (Details) - USD ($)
1 Months Ended
Oct. 22, 2021
Oct. 22, 2021
Sep. 30, 2023
Private Placement [Member]      
Private Placement [Line Items]      
Shares issued (in Shares)   1,060,000  
Price per share $ 10 $ 10  
Gross proceeds amount (in Dollars) $ 10,600,000    
Class A Common Stock [Member]      
Private Placement [Line Items]      
Price per share     $ 11.5
v3.23.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 20, 2023
Jul. 07, 2023
Jun. 04, 2021
May 19, 2023
Jan. 17, 2023
Sep. 23, 2021
Jun. 24, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Oct. 22, 2021
Related Party Transactions (Details) [Line Items]                          
Sponsor repaid amount             $ 25,000            
Sponsor shares (in Shares)             5,900,000            
Stock split, description                   the Company effected a 1.36440678 for 1 stock split      
Aggregate founder shares (in Shares)           8,050,000              
Aggregate principal amount   $ 900,000   $ 600,000                  
Borrowed amount                         $ 117,994
Outstanding balance                    
Price per shares (in Dollars per share)               $ 10   $ 10      
Principal amounts         $ 676,149                
Support services incurred amount               $ 30,000 $ 30,000 $ 90,000 $ 90,000    
Extension fees                   676,149      
Working capital               1,414,717   1,414,717   0  
Promissory note $ 180,000                        
Conversion price per unit (in Dollars per share) $ 10                        
Working capita $ 1,500,000                        
Working capital loans               1.5   1.5      
Due to related parties               82,605   82,605   $ 0  
Sponsor amount                   10,000      
Incurred cost                   10,000      
Sponsor [Member]                          
Related Party Transactions (Details) [Line Items]                          
Loan amount               510,000   $ 510,000      
Maximum [Member]                          
Related Party Transactions (Details) [Line Items]                          
Ordinary share issued percentage                   75.00%      
Minimum [Member]                          
Related Party Transactions (Details) [Line Items]                          
Ordinary share issued percentage                   25.00%      
Promissory Note [Member]                          
Related Party Transactions (Details) [Line Items]                          
Aggregate principal amount     $ 300,000                    
Principal amounts         $ 400,000                
Support services incurred amount                   $ 738,568      
Sponsor [Member]                          
Related Party Transactions (Details) [Line Items]                          
Sponsor paid per share (in Dollars per share)         $ 10                
Shares issued (in Shares)                   1      
Sponsor [Member] | Class B Common Stock [Member]                          
Related Party Transactions (Details) [Line Items]                          
Common stock shares (in Shares)     5,900,000                    
Founder Shares [Member]                          
Related Party Transactions (Details) [Line Items]                          
Sponsor paid per share (in Dollars per share)                   $ 0.003      
Agreed to forfeit (in Shares)                   1,050,000      
Working capital loans               1.5   $ 1.5      
Support services incurred amount                   $ 161,432      
Shares issued (in Shares)                   1      
Private Placement [Member]                          
Related Party Transactions (Details) [Line Items]                          
Working capital loans               1,500,000   $ 1,500,000      
Related Party Loans [Member] | Sponsor [Member]                          
Related Party Transactions (Details) [Line Items]                          
Loan amount               $ 230,000   $ 230,000      
v3.23.3
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 9 Months Ended
Oct. 19, 2023
Sep. 29, 2023
Dec. 08, 2022
Jul. 28, 2022
Oct. 22, 2021
Aug. 18, 2023
Jun. 20, 2023
Jun. 19, 2023
May 19, 2023
Apr. 18, 2023
Mar. 20, 2023
Feb. 17, 2023
Jan. 17, 2023
Sep. 30, 2023
Dec. 31, 2022
Jun. 04, 2021
Commitments and Contingencies [Line Items]                                
Underwriting discount (in Dollars)                           $ 0.2    
Underwriting commissions (in Dollars)     $ 8,650,000                          
Total deferred fee (in Dollars)                           8,650,000    
Deferred portion (in Dollars)                           8,050,000    
Deferred cash discount (in Dollars)                           600,000    
Aggregate consideration amount (in Dollars)       $ 800,000,000                        
Unvested shares       30,000,000                        
Price per share (in Dollars per share)       $ 0.0001                        
Total funded amount (in Dollars)                           $ 15,000,000    
Warrant exchange (in Dollars per share)   $ 0.175                            
Share tranches                           5,000,000    
Remaining of earn-out shares                           10,000,000    
Aggregate indemnity amount (in Dollars)                           $ 4,000,000    
Aggregate shares of common stock                           1,500,000    
Purchase share percentage                           9.90%    
Public stockholders percentage                           10.00%    
Terminated shares (in Dollars per share)                           $ 2.5    
Forward purchase shares               1.00%           9.90%    
Loan amount of sponsor (in Dollars)           $ 60,000 $ 112,691   $ 112,691 $ 112,691 $ 112,691 $ 112,691 $ 112,691      
Investor loan amount (in Dollars)                           $ 510,000    
Forward Purchase Agreement [Member]                                
Commitments and Contingencies [Line Items]                                
Public stockholders percentage                           10.00%    
Maximum [Member]                                
Commitments and Contingencies [Line Items]                                
Earn-out shares 30,000,000                              
Minimum [Member]                                
Commitments and Contingencies [Line Items]                                
Earn-out shares 20,000,000                              
Share-Based Payment Arrangement, Tranche One [Member]                                
Commitments and Contingencies [Line Items]                                
Price per shares (in Dollars per share)                           $ 12.5    
Share-Based Payment Arrangement, Tranche Two [Member]                                
Commitments and Contingencies [Line Items]                                
Price per shares (in Dollars per share)                           15    
Share-Based Payment Arrangement, Tranche Three [Member]                                
Commitments and Contingencies [Line Items]                                
Price per shares (in Dollars per share)                           20    
Share Based Compensation Award Tranche Four [Member]                                
Commitments and Contingencies [Line Items]                                
Price per shares (in Dollars per share)                           25    
Athena Warrants [Member]                                
Commitments and Contingencies [Line Items]                                
Issued ordinary share (in Dollars per share)                           $ 0.12    
Over-Allotment Option [Member]                                
Commitments and Contingencies [Line Items]                                
Additional units                           3,000,000    
Purchasing units         3,000,000                      
Cash underwriting discount price per share (in Dollars per share)                           $ 0.2    
Business combination (in Dollars)                           $ 600,000    
IPO [Member]                                
Commitments and Contingencies [Line Items]                                
Underwriter exercise price (in Dollars)                           $ 4,000,000    
Underwriting commissions per unit (in Dollars per share)                           $ 0.35    
Underwriting commissions (in Dollars)                           $ 8,050,000    
Class A Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Additional units                 1              
Converted common stock share       1                        
Common stock shares par value (in Dollars per share)                           $ 0.0001 $ 0.0001  
Price per shares (in Dollars per share)                           11.5    
Nominal value of per share (in Dollars per share)                           $ 11.5    
Aggregate ordinary share   100,000                            
Class A Common Stock [Member] | Forward Purchase Agreement [Member]                                
Commitments and Contingencies [Line Items]                                
Aggregate shares of common stock                           15,000,000    
Class A Common Stock [Member] | Athena Warrants [Member]                                
Commitments and Contingencies [Line Items]                                
Common stock shares par value (in Dollars per share)                           $ 0.0001    
Warrant exchange (in Dollars per share)                           0.175    
Class B Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Common stock shares par value (in Dollars per share)                           $ 0.0001 $ 0.0001  
Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Converted common stock share       1                        
Exchanged ordinary share   1   1                        
Common stock shares par value (in Dollars per share)   $ 0.0001                            
Subsequent Event [Member]                                
Commitments and Contingencies [Line Items]                                
Exchanged ordinary share 1                              
Common stock shares par value (in Dollars per share) $ 0.0001                              
Remaining of earn-out shares 10,000,000                              
Nominal value of per share (in Dollars per share) $ 0.12                              
Aggregate ordinary share 79,019,608                              
Subsequent Event [Member] | Class A Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Common stock shares par value (in Dollars per share) $ 0.0001                              
Subsequent Event [Member] | Class B Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Common stock shares par value (in Dollars per share) $ 0.0001                              
Subsequent Event [Member] | Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Converted common stock share 1                              
Topco [Member] | Athena Warrants [Member] | Maximum [Member]                                
Commitments and Contingencies [Line Items]                                
Earn-out shares                           30,000,000    
Topco [Member] | Athena Warrants [Member] | Minimum [Member]                                
Commitments and Contingencies [Line Items]                                
Earn-out shares                           20,000,000    
Topco [Member] | Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Nominal value of per share (in Dollars per share)   $ 0.12                            
Topco [Member] | Subsequent Event [Member] | Athena Warrants [Member]                                
Commitments and Contingencies [Line Items]                                
Warrant exchange (in Dollars per share) $ 0.175                              
Sponsor [Member]                                
Commitments and Contingencies [Line Items]                                
Ordinary share issued percentage       75.00%                        
Shares issued                           1    
Sponsor [Member] | Class B Common Stock [Member]                                
Commitments and Contingencies [Line Items]                                
Aggregate ordinary share                               5,900,000
Founder Shares [Member]                                
Commitments and Contingencies [Line Items]                                
Shares issued                           1    
Funded amount (in Dollars)                           $ 1.5    
Subscription Agreement [Member]                                
Commitments and Contingencies [Line Items]                                
Loan amount of sponsor (in Dollars)                           $ 230,000    
Second Amendment to the Business Combination Agreement [Member]                                
Commitments and Contingencies [Line Items]                                
Business combination agreement descriptions                           (a) Treatment of Athena Class B Common Stock – In connection with the closing of the Business Combination and subject to the approval of the Company’s stockholders, each issued and outstanding share of the Company’s Class B common stock will be converted into 1.05 TopCo ordinary shares, or a conversion of 8,050,000 shares into 8,452,500 shares. The 1:1.05 conversion ratio is a clarification and finalization of the conversion ratio of such shares originally contemplated by the First Amendment to the Business Combination Agreement, which was based on the amount that may have been funded under the Bridge Financing. Final disbursement amounts under the Bridge Financing totaled $3,750,000 out of a maximum of $15,000,000, resulting in a 1:1.05 conversion ratio under the First Amendment to the Business Combination Agreement out of a maximum 1:1.2 conversion ratio; (b) Requisite Lock-up Percentage of e.GO Shareholders and Convertible Note Lenders – The Business Combination Agreement previously required all of e.GO’s shareholders and convertible loan lenders to enter into lock-up agreements pursuant to which they agreed not to effect any sale or distribution of any equity securities of TopCo issued to them at the closing of the Business Combination until the date that is six months after the closing. Pursuant to the Second Amendment to the Business Combination Agreement, such requirement was reduced to restrict the sale or distribution of 75% of the pro forma share capital of e.GO on a fully diluted basis as of the date of the Second Amendment to the Business Combination Agreement; and (c) Outside Date Termination Event – The outside date to terminate the Business Combination Agreement was extended from September 30, 2023 to September 30, 2023.    
Topco [Member]                                
Commitments and Contingencies [Line Items]                                
Aggregate ordinary share       79,019,608                        
Aggregate shares of common stock                           15,000,000    
Bridge Financing [Member]                                
Commitments and Contingencies [Line Items]                                
Total funded amount (in Dollars)       $ 15,000,000                        
v3.23.3
Stockholders’ Deficit (Details) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 29, 2023
Dec. 31, 2022
Stockholders’ Deficit (Details) [Line Items]      
Percentage of common stock 26.00%    
Total funded amount (in Dollars) $ 15,000,000    
Preferred stock shares authorized 1,000,000   1,000,000
Preferred stock par value (in Dollars per share) $ 0.0001   $ 0.0001
Public warrants     11,500,000
Private Placement Warrants     530,000
Warrants expire 5 years    
Warrants exercisable, description Once the Warrants become exercisable, the Company may redeem the Warrants:   ● in whole and not in part;         ● at a price of $0.01 per Warrant;         ● upon not less than 30 days’ prior written notice of redemption, to each Warrant holder; and         ● if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share consolidations, share capitalizations, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the Warrant holders.    
Business combination of common stock, description In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price.    
Public Warrants [Member]      
Stockholders’ Deficit (Details) [Line Items]      
Public warrants 11,500,000    
Private Placement Warrants [Member]      
Stockholders’ Deficit (Details) [Line Items]      
Private Placement Warrants 530,000    
Class A Common Stock [Member]      
Stockholders’ Deficit (Details) [Line Items]      
Common stock shares authorized 100,000,000   100,000,000
Common stock par value (in Dollars per share) $ 0.0001   $ 0.0001
Common stock shares issued 1,060,000 884,880 1,060,000
Common stock shares outstanding 1,060,000   1,060,000
Common stock subject to possible redemption, redemption value 181,460   2,048,936
Class B Common Stock [Member]      
Stockholders’ Deficit (Details) [Line Items]      
Common stock shares authorized 10,000,000   10,000,000
Common stock par value (in Dollars per share) $ 0.0001   $ 0.0001
Common stock shares issued 8,050,000   8,050,000
Common stock shares outstanding 8,050,000   8,050,000
Common stock voting rights one    
v3.23.3
Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities that are Measured at Fair Value - Fair Value, Recurring [Member] - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Quoted Prices in Active Markets (Level 1)    
Assets:    
Cash and Investments held in Trust Account $ 10,673,205 $ 21,752,492
Liabilities:    
Derivative liability – Forward Purchase Agreement  
Significant Other Observable Inputs (Level 2)    
Assets:    
Cash and Investments held in Trust Account
Liabilities:    
Derivative liability – Forward Purchase Agreement  
Significant Other Unobservable Inputs (Level 3)    
Assets:    
Cash and Investments held in Trust Account
Liabilities:    
Derivative liability – Forward Purchase Agreement   $ 1,730,000
v3.23.3
Fair Value Measurements (Details) - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements - Fair Value, Inputs, Level 3 [Member]
12 Months Ended
Dec. 31, 2022
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Risk-free interest rate 4.40%
Term 2 years 3 months
Expected volatility 78.20%
Exercise price (in Dollars per share) $ 2.5
Stock price (in Dollars per share) $ 10.38
Probability of transaction 50.00%
v3.23.3
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Forward Purchase Agreement - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2022
Sep. 30, 2023
Schedule of Changes in the Fair Value of Forward Purchase Agreement [Abstract]    
Fair value beginning $ 1,430,000 $ 1,730,000
Change in valuation inputs or other assumptions 300,000  
Fair value ending $ 1,730,000
Gain on termination of derivative liability – Forward Purchase Agreement   $ (1,730,000)
v3.23.3
Subsequent Events (Details)
$ / shares in Units, $ in Thousands
1 Months Ended
Nov. 02, 2023
USD ($)
shares
Oct. 19, 2023
$ / shares
€ / shares
shares
Jun. 19, 2023
shares
Sep. 30, 2023
shares
Subsequent Events (Details) [Line Items]        
Unvested earn out of shares       20,000,000
Business combination percentage       85.00%
Outstanding percentage       21.00%
Payment by company     1,082,596  
Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Aggregate share   79,019,608    
Nominal value per share (in Euro per share) | € / shares   € 0.12    
Shares issued   30,000,000    
Unvested earn out of shares   20,000,000    
Shares issued   10,000,000    
Exchange per share (in Dollars per share) | $ / shares   € 0.175    
Payment by company 784,880      
Stockholders amount (in Dollars) | $ $ 8,670      
Class A Common Stock [Member]        
Subsequent Events (Details) [Line Items]        
Aggregate shares       784,880
Class A Common Stock [Member] | Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Common stock par value (in Dollars per share) | $ / shares   0.0001    
Class B Common Stock [Member] | Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Common stock par value (in Dollars per share) | $ / shares   0.0001    
Common Stock [Member] | Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Common stock par value (in Dollars per share) | $ / shares   € 0.0001    

Athena Consumer Acquisit... (NYSE:ACAQ)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Athena Consumer Acquisit... 차트를 더 보려면 여기를 클릭.
Athena Consumer Acquisit... (NYSE:ACAQ)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Athena Consumer Acquisit... 차트를 더 보려면 여기를 클릭.